SCAN results

Study (identified by PubMed ID)	Disease/Trait	P-value	Platform [SNPs passing QC]	Region	Reported Gene(s)	Reported SNPs
19169254	Psoriasis	Pending	Perlegen [~2.5 million] (imputed)	Pending	Pending	rs20541
19169254	Psoriasis	Pending	Perlegen [~2.5 million] (imputed)	Pending	Pending	rs12191877
19169254	Psoriasis	Pending	Perlegen [~2.5 million] (imputed)	Pending	Pending	rs17728338
19169254	Psoriasis	Pending	Perlegen [~2.5 million] (imputed)	Pending	Pending	rs610604
19169254	Psoriasis	Pending	Perlegen [~2.5 million] (imputed)	Pending	Pending	rs2201841
19169254	Psoriasis	Pending	Perlegen [~2.5 million] (imputed)	Pending	Pending	rs2066808
19169254	Psoriasis	Pending	Perlegen [~2.5 million] (imputed)	Pending	Pending	rs1076160
19169254	Psoriasis	Pending	Perlegen [~2.5 million] (imputed)	Pending	Pending	rs2082412
19169255	Psoriasis	3.00E-26	Illumina [494,902]	5q33.3	IL12B	rs3213094
19169255	Psoriasis	7.00E-30	Illumina [494,902]	1q21.3	LCE3D, LCE3A	rs4085613
19169255	Psoriasis	NS	Illumina [494,902]	6p21.33	MHC	rs1265181
19148276	Plasma levels of polyunsaturated fatty acids	Pending	Illumina [495,343]	Pending	Pending
19132087	Kawasaki disease	0.000001	Affymetrix [223,922]	3q26.31	NAALADL2	rs17531088
19132087	Kawasaki disease	0.000002	Affymetrix [223,922]	16q22.3	ZFHX3	rs7199343
19124843	Plasma Lp (a) levels	4.00E-11	Affymetrix [290,327]	6q25.3	LPA	rs6919346
19122664	Ulcerative colitis	7.00E-09	Illumina [280,748]	1p36.13	RNF186	rs3806308
19122664	Ulcerative colitis	0.000002	Illumina [280,748]	9q21.32	Intergenic	rs668853
19122664	Ulcerative colitis	5.00E-07	Illumina [280,748]	12q15	IL26	rs2870946
19122664	Ulcerative colitis	3.00E-12	Illumina [280,748]	12q15	IFNG, IL26, IL22	rs1558744
19122664	Ulcerative colitis	1.00E-16	Illumina [280,748]	6p21.32	BTNL2, HLA-DRA, HLA-DRB5, HLA-DRB1, HLA-DQA1, HLA-DQB1	rs2395185
19122664	Ulcerative colitis	1.00E-08	Illumina [280,748]	1p31.3	IL23R	rs11209026
19122664	Ulcerative colitis	0.000009	Illumina [280,748]	7q31.1	SLC26A3, DLD, LAMB1	rs4730276
19122664	Ulcerative colitis	0.000007	Illumina [280,748]	7q31.1	SLC26A3, DLD, LAMB1	rs2158836
19122664	Ulcerative colitis	1.00E-08	Illumina [280,748]	1p31.3	IL23R	rs10889677
19122664	Ulcerative colitis	0.000001	Illumina [280,748]	7q31.1	SLC26A3, DLD, LAMB1	rs4598195
19122664	Ulcerative colitis	5.00E-13	Illumina [280,748]	1p36.13	OTUD3, PLA2G2E	rs6426833
19122664	Ulcerative colitis	0.000005	Illumina [280,748]	7q31.1	Intergenic	rs4730273
19118814	Alzheimer's disease	0.000002	Illumina [~2.5 million] (imputed)	19q13.31	ZNF224	rs2061333
19118814	Alzheimer's disease	3.00E-07	Illumina [~2.5 million] (imputed)	12q13.11	FAM113B	rs11610206
19118814	Alzheimer's disease	0.000009	Illumina [~2.5 million] (imputed)	1q42.2	DISC1	rs12044355
19115949	AIDS progression	6.00E-08	Illumina [291,119]	6p21.33	HLA-C	rs10484554
19115949	AIDS progression	3.00E-19	Illumina [291,119]	6p21.33	HCP5, MICB, MCCD1, BAT1, LTB, TNF	rs2395029
19115949	AIDS progression	5.00E-07	Illumina [291,119]	6p21.33	ZNRD1, RNF39	rs8321
19114987	Bipolar disorder	Pending	Affymetrix [51,757 CNVs]	Pending	Pending
19114657	Blood pressure	2.00E-07	Affymetrix [79,447]	2q24.3	STK39	rs6749447
19110211	Mean platelet volume	7.00E-48	Affymetrix [335,152]	12q24.31	WDR66	rs7961894
19110211	Mean platelet volume	7.00E-28	Affymetrix [335,152]	17q11.2	TAOK1	rs2138852
19110211	Mean platelet volume	4.00E-27	Affymetrix [335,152]	3p14.3	ARHGEF3	rs12485738
19107115	Major depressive disorder	0.000006	Illumina and Affymetrix [494,678] (imputed)	12p13.32	CCND2	rs4238010
19084217	Serum markers of iron status	1.00E-09	Affymetrix [100,846]	3q22.1	TF	rs1830084
19084217	Serum markers of iron status	1.00E-10	Illumina [315,887]	6p22.1	HFE	rs1800562
19084217	Serum markers of iron status	6.00E-08	Illumina [315,887]	6p22.1	BTN1A1	rs13194984
19084217	Serum markers of iron status	1.00E-08	Illumina [315,887]	6p22.1	HIST1H2BJ	rs13194491
19084217	Serum markers of iron status	4.00E-15	Illumina [315,887]	6p22.1	HFE	rs1800562
19084217	Serum markers of iron status	0.000002	Illumina [315,887]	11p14.3	LUZP2	rs10500991
19084217	Serum markers of iron status	0.000002	Illumina [315,887]	3q22.1	TF	rs1867504
19084217	Serum markers of iron status	0.000002	Illumina [315,887]	Xq24	KLHL13	rs2430212
19084217	Serum markers of iron status	0.000001	Illumina [315,887]	3q22.1	TOPBP1	rs2718812
19084217	Serum markers of iron status	3.00E-07	Illumina [315,887]	6p22.2	LRRC16	rs2274089
19084217	Serum markers of iron status	3.00E-15	Illumina [315,887]	3q22.1	TF	rs3811647
19084217	Serum markers of iron status	0.000008	Illumina [315,887]	18q22.2	Intergenic	rs2660917
19084217	Serum markers of iron status	0.000008	Illumina [315,887]	5q14.1	ARSB	rs2052550
19084217	Serum markers of iron status	0.000007	Illumina [315,887]	7p14.1	Q4KMW4	rs29880
19084217	Serum markers of iron status	0.000001	Illumina [315,887]	6q25.3	WTAP	rs4516970
19084217	Serum markers of iron status	0.000008	Illumina [315,887]	5p12	GHR	rs13188386
19084217	Serum markers of iron status	0.000004	Illumina [315,887]	6p22.1	TRIM38	rs12216125
19084217	Serum markers of iron status	0.000003	Illumina [315,887]	2p14	Q6ZNG6	rs1457451
19084217	Serum markers of iron status	8.00E-07	Illumina [315,887]	6p22.2	LRRC16	rs2274089
19084217	Serum markers of iron status	4.00E-11	Illumina [315,887]	6p22.1	HFE	rs1800562
19084217	Serum markers of iron status	0.000005	Illumina [315,887]	3q22.1	TF	rs1799852
19084217	Serum markers of iron status	0.000005	Illumina [315,887]	6p22.2	LRRC16A	rs2274089
19084217	Serum markers of iron status	0.000009	Illumina [315,887]	6p22.2	SCGN	rs932316
19084217	Serum markers of iron status	5.00E-07	Illumina [315,887]	6p22.2	SLC17A1	rs17270561
19084217	Serum markers of iron status	0.000003	Affymetrix [100,846]	14q23.2	Q6ZUR9	rs973968
19084217	Serum markers of iron status	0.000006	Illumina [315,887]	22q12.3	TMPRSS6	rs4820268
19084217	Serum markers of iron status	0.000002	Affymetrix [100,846]	6q22.33	RSPO3	rs972275
19074352	Triglycerides	3.00E-29	Affymetrix [381,934]	11q23.3	APOA1, APOC3, APOA4, APOA5, DSCAML1	rs10892151
19079262	Bone mineral density (hip)	4.00E-10	Illumina [305,051]	6q25.1	ESR1	rs1038304
19079262	Bone mineral density (hip)	9.00E-07	Illumina [305,051]	17q21.31	C17orf53	rs227584
19079262	Bone mineral density (hip)	2.00E-08	Illumina [305,051]	17q21.31	SOST	rs1513670
19079262	Bone mineral density (hip)	0.000001	Illumina [305,051]	Xq21.2	NR	rs2710057
19079262	Bone mineral density (hip)	7.00E-07	Illumina [305,051]	11p11.2	LRP4	rs1007738
19079262	Bone mineral density (hip)	0.000009	Illumina [305,051]	3p22.1	NR	rs10490823
19079262	Bone mineral density (hip)	0.000002	Illumina [305,051]	2q12.1	NR	rs6735786
19079262	Bone mineral density (hip)	1.00E-16	Illumina [305,051]	1p36.12	Intergenic	rs7524102
19079262	Bone mineral density (spine)	2.00E-17	Illumina [305,051]	13q14.11	RANKL	rs9594759
19079262	Bone mineral density (spine)	0.000006	Illumina [305,051]	21q11.2	NR	rs1006899
19079262	Bone mineral density (spine)	0.000004	Illumina [305,051]	2p16.2	SPTBN1	rs11898505
19079262	Bone mineral density (spine)	2.00E-10	Illumina [305,051]	6q25.1	C6orf97, ESR1	rs6929137
19079262	Bone mineral density (spine)	0.000004	Illumina [305,051]	2p22.2	LOC344382	rs4670779
19079262	Bone mineral density (spine)	2.00E-08	Illumina [305,051]	1p36.12	Intergenic	rs6696981
19079262	Bone mineral density (spine)	1.00E-07	Illumina [305,051]	12q13.13	OSX	rs10876432
19079260	Body mass index	6.00E-08	Illumina [305,846]	1q25.2	SEC16B, RASAL2	rs10913469
19079260	Body mass index	7.00E-12	Illumina [305,846]	19q13.11	KCTD15, CHST8	rs29941
19079260	Body mass index	1.00E-12	Illumina [305,846]	18q21.32	MC4R	rs12970134
19079260	Body mass index	1.00E-47	Illumina [305,846]	16q12.2	FTO	rs8050136
19079260	Body mass index	9.00E-10	Illumina [305,846]	11p14.1	BDNF	rs925946
19079260	Body mass index	0.000008	Illumina [305,846]	11p14.1	BDNF	rs7481311
19079260	Body mass index	7.00E-11	Illumina [305,846]	3q27.2	SFRS10, ETV5, DGKG	rs7647305
19079260	Body mass index	4.00E-17	Illumina [305,846]	2p25.3	TMEM18	rs7561317
19079260	Body mass index	1.00E-11	Illumina [305,846]	1p31.1	NEGR1	rs2568958
19079260	Body mass index	0.000004	Illumina [305,846]	1p21.3	NR	rs10783050
19079260	Body mass index	5.00E-10	Illumina [305,846]	11p14.1	BDNF	rs6265
19079260	Body mass index	1.00E-07	Illumina [305,846]	12q13.13	BCDIN3D, FAIM2	rs7138803
19079260	Body mass index	4.00E-13	Illumina [305,846]	16q12.2	FTO	rs6499640
19079260	Body mass index	3.00E-10	Illumina [305,846]	16p11.2	SH2B1, ATP2A1	rs7498665
19079260	Weight	2.00E-18	Illumina [305,846]	2p25.3	TMEM18	rs7561317
19079260	Weight	2.00E-08	Illumina [305,846]	6p21.33	AIF1, NCR3	rs2844479
19079260	Weight	4.00E-09	Illumina [305,846]	3q27.2	SFRS10, ETV5, DGKG	rs7647305
19079260	Weight	4.00E-09	Illumina [305,846]	11p14.1	BDNF	rs925946
19079260	Weight	0.000003	Illumina [305,846]	11p14.1	BDNF	rs7481311
19079260	Weight	1.00E-08	Illumina [305,846]	1q25.2	SEC16B, RASAL2	rs10913469
19079260	Weight	2.00E-08	Illumina [305,846]	1p31.1	NEGR1	rs2568958
19079260	Weight	0.000002	Illumina [305,846]	5q23.2	NR	rs2115172
19079260	Weight	0.000001	Illumina [305,846]	1p21.3	NR	rs1973993
19079260	Weight	5.00E-09	Illumina [305,846]	19q13.11	KCTD15, CHST8	rs29941
19079260	Weight	5.00E-13	Illumina [305,846]	18q21.32	MC4R	rs12970134
19079260	Weight	5.00E-36	Illumina [305,846]	16q12.2	FTO	rs8050136
19079260	Weight	6.00E-14	Illumina [305,846]	16q12.2	FTO	rs6499640
19079260	Weight	1.00E-09	Illumina [305,846]	16p11.2	SH2B1, ATP2A1	rs7498665
19079260	Weight	0.000001	Illumina [305,846]	13q12.2	NR	rs7336332
19079260	Weight	2.00E-07	Illumina [305,846]	12q13.13	BCDIN3D, FAIM2	rs7138803
19079260	Weight	2.00E-07	Illumina [305,846]	11p14.1	BDNF	rs6265
19079261	Body mass index	4.00E-51	Illumina and Affymetrix [2,399,588] (imputed)	16q12.2	FTO	rs9939609
19079261	Body mass index	3.00E-16	Illumina and Affymetrix [2,399,588] (imputed)	4p13	GNPDA2	rs10938397
19079261	Body mass index	5.00E-09	Illumina and Affymetrix [2,399,588] (imputed)	11p11.2	MTCH2	rs10838738
19079261	Body mass index	6.00E-08	Illumina and Affymetrix [2,399,588] (imputed)	1p31.1	NEGR1	rs2815752
19079261	Body mass index	0.000007	Illumina and Affymetrix [2,399,588] (imputed)	15q25.2	RKHD3	rs12324805
19079261	Body mass index	0.000006	Illumina and Affymetrix [2,399,588] (imputed)	20p12.3	BMP2	rs2145270
19079261	Body mass index	0.000001	Illumina and Affymetrix [2,399,588] (imputed)	11p15.4	STK33	rs10769908
19079261	Body mass index	2.00E-08	Illumina and Affymetrix [2,399,588] (imputed)	19q13.11	KCTD15	rs11084753
19079261	Body mass index	5.00E-11	Illumina and Affymetrix [2,399,588] (imputed)	16p11.2	SH2B1	rs7498665
19079261	Body mass index	5.00E-18	Illumina and Affymetrix [2,399,588] (imputed)	18q21.32	MC4R	rs17782313
19079261	Body mass index	1.00E-18	Illumina and Affymetrix [2,399,588] (imputed)	2p25.3	TMEM18	rs6548238
19081515	Creutzfeldt-Jakob disease	2.00E-21	Affymetrix [288,908]	20p13	PRNP	rs1799990
19081515	Creutzfeldt-Jakob disease	6.00E-08	Affymetrix [288,908]	8q21.13	STMN2	rs1460163
19065144	Major depressive disorder	NS	Perlegen [435,291]	NR	NR
19060911	Cholesterol, total	5.00E-10	Illumina and Affymetrix [up to ~600,000]	1p36.11	TMEM57	rs10903129
19060911	Cholesterol, total	9.00E-24	Illumina and Affymetrix [up to ~600,000]	19p13.2	LDLR	rs2228671
19060911	Cholesterol, total	3.00E-19	Illumina and Affymetrix [up to ~600,000]	19q13.32	TOMM40, APOE	rs2075650
19060911	Cholesterol, total	2.00E-15	Illumina and Affymetrix [up to ~600,000]	19p13.11	NCAN	rs2304130
19060911	Cholesterol, total	2.00E-11	Illumina and Affymetrix [up to ~600,000]	18q21.1	LIPG	rs4939883
19060911	Cholesterol, total	9.00E-23	Illumina and Affymetrix [up to ~600,000]	2p24.1	APOB	rs693
19060911	Cholesterol, total	2.00E-10	Illumina and Affymetrix [up to ~600,000]	11q12.2	FADS2, FADS3	rs174570
19060911	Cholesterol, total	4.00E-12	Illumina and Affymetrix [up to ~600,000]	1p31.3	DOCK7	rs10889353
19060911	Cholesterol, total	9.00E-22	Illumina and Affymetrix [up to ~600,000]	1p13.3	CELSR2	rs646776
19060911	Cholesterol, total	2.00E-11	Illumina and Affymetrix [up to ~600,000]	2p21	ABCG5	rs6756629
19060911	Cholesterol, total	4.00E-07	Illumina and Affymetrix [up to ~600,000]	15q22.1	LIPC	rs1532085
19060911	Cholesterol, total	7.00E-07	Illumina and Affymetrix [up to ~600,000]	11q23.3	APOA1, APOA4, APOA5, APOC3	rs12272004
19060911	Cholesterol, total	3.00E-09	Illumina and Affymetrix [up to ~600,000]	8q24.13	TRIB1	rs6987702
19060911	Cholesterol, total	9.00E-07	Illumina and Affymetrix [up to ~600,000]	7p15.3	DNAH11	rs12670798
19060911	Cholesterol, total	3.00E-19	Illumina and Affymetrix [up to ~600,000]	5q13.3	HMGCR	rs3846662
19060911	HDL cholesterol	6.00E-11	Illumina and Affymetrix [up to ~600,000]	11p11.2	MADD, FOLH1	rs7395662
19060911	HDL cholesterol	8.00E-16	Illumina and Affymetrix [up to ~600,000]	16q22.1	CTCF, PRMT8	rs2271293
19060911	HDL cholesterol	4.00E-08	Illumina and Affymetrix [up to ~600,000]	2p24.1	APOB	rs6754295
19060911	HDL cholesterol	9.00E-13	Illumina and Affymetrix [up to ~600,000]	9q31.1	ABCA1	rs3905000
19060911	HDL cholesterol	1.00E-35	Illumina and Affymetrix [up to ~600,000]	15q22.1	LIPC	rs1532085
19060911	HDL cholesterol	4.00E-07	Illumina and Affymetrix [up to ~600,000]	19q13.32	TOMM40, APOE	rs157580
19060911	HDL cholesterol	2.00E-11	Illumina and Affymetrix [up to ~600,000]	18q21.1	LIPG	rs4939883
19060911	HDL cholesterol	0.000004	Illumina and Affymetrix [up to ~600,000]	11q12.2	FADS2, FADS3	rs174570
19060911	HDL cholesterol	6.00E-18	Illumina and Affymetrix [up to ~600,000]	8p21.3	LPL	rs2083637
19060911	HDL cholesterol	9.00E-94	Illumina and Affymetrix [up to ~600,000]	16q13	CETP	rs1532624
19060911	LDL cholesterol	4.00E-17	Illumina and Affymetrix [up to 600,000]	2p24.1	APOB	rs693
19060911	LDL cholesterol	5.00E-13	Illumina and Affymetrix [up to 600,000]	11q23.3	APOA1, APOA4, APOA5, APOC3	rs12272004
19060911	LDL cholesterol	2.00E-19	Illumina and Affymetrix [up to 600,000]	19q13.32	TOMM40, APOE	rs157580
19060911	LDL cholesterol	0.000003	Illumina and Affymetrix [up to 600,000]	19p13.11	NCAN	rs2304130
19060911	LDL cholesterol	4.00E-14	Illumina and Affymetrix [up to 600,000]	19p13.2	LDLR	rs2228671
19060911	LDL cholesterol	0.000003	Illumina and Affymetrix [up to 600,000]	8q24.13	TRIB1	rs6987702
19060911	LDL cholesterol	3.00E-10	Illumina and Affymetrix [up to 600,000]	2p21	ABCG5	rs6756629
19060911	LDL cholesterol	0.000008	Illumina and Affymetrix [up to 600,000]	1p31.3	DOCK7	rs10889353
19060911	LDL cholesterol	8.00E-23	Illumina and Affymetrix [up to 600,000]	1p13.3	CELSR2	rs646776
19060911	LDL cholesterol	2.00E-11	Illumina and Affymetrix [up to 600,000]	5q13.3	HMGCR	rs3846662
19060911	LDL cholesterol	4.00E-13	Illumina and Affymetrix [up to 600,000]	11q12.2	FADS2, FADS3	rs174570
19060911	LDL cholesterol	6.00E-09	Illumina and Affymetrix [up to 600,000]	7p15.3	DNAH11	rs12670798
19060911	Triglycerides	2.00E-12	Illumina and Affymetrix [up to 600,000]	1p31.3	DOCK7	rs1167998
19060911	Triglycerides	5.00E-13	Illumina and Affymetrix [up to 600,000]	11q23.3	APOA1, APOA4, APOA5, APOC3	rs12272004
19060911	Triglycerides	1.00E-12	Illumina and Affymetrix [up to 600,000]	7q11.23	MLXIPL	rs2240466
19060911	Triglycerides	0.000003	Illumina and Affymetrix [up to 600,000]	19p13.11	NCAN	rs2304130
19060911	Triglycerides	3.00E-20	Illumina and Affymetrix [up to 600,000]	2p23.3	GCKR	rs780094
19060911	Triglycerides	2.00E-09	Illumina and Affymetrix [up to 600,000]	19q13.32	TOMM40, APOE	rs439401
19060911	Triglycerides	2.00E-18	Illumina and Affymetrix [up to 600,000]	8p21.3	LPL	rs10096633
19060911	Triglycerides	3.00E-08	Illumina and Affymetrix [up to 600,000]	2p24.1	APOB	rs6754295
19060909	Fasting plasma glucose	2.00E-36	Illumina [308,846]	11q21	MTNR1B	rs1387153
19060906	HDL cholesterol	2.00E-12	Affymetrix and Illumina [~2,600,000] (imputed)	11q12.2	FADS1, FADS2, FADS3	rs174547
19060906	HDL cholesterol	8.00E-10	Affymetrix and Illumina [~2,600,000] (imputed)	20q13.2	HNF4A	rs1800961
19060906	HDL cholesterol	3.00E-10	Affymetrix and Illumina [~2,600,000] (imputed)	9p22.3	TTC39B	rs471364
19060906	HDL cholesterol	4.00E-09	Affymetrix and Illumina [~2,600,000] (imputed)	20q13.12	PLTP	rs7679
19060906	HDL cholesterol	9.00E-13	Affymetrix and Illumina [~2,600,000] (imputed)	16q22.1	LCAT	rs2271293
19060906	HDL cholesterol	2.00E-34	Affymetrix and Illumina [~2,600,000] (imputed)	8p21.3	LPL	rs12678919
19060906	HDL cholesterol	7.00E-15	Affymetrix and Illumina [~2,600,000] (imputed)	18q21.1	LIPG	rs4939883
19060906	HDL cholesterol	1.00E-10	Affymetrix and Illumina [~2,600,000] (imputed)	12q24.11	MMAB,MVK	rs2338104
19060906	HDL cholesterol	4.00E-08	Affymetrix and Illumina [~2,600,000] (imputed)	1q42.13	GALNT2	rs4846914
19060906	HDL cholesterol	1.00E-09	Affymetrix and Illumina [~2,600,000] (imputed)	9q31.1	ABCA1	rs1883025
19060906	HDL cholesterol	1.00E-12	Affymetrix and Illumina [~2,600,000] (imputed)	11q23.3	APOA1, APOC3, APOA4, APOA5	rs964184
19060906	HDL cholesterol	8.00E-23	Affymetrix and Illumina [~2,600,000] (imputed)	15q22.1	LIPC	rs10468017
19060906	HDL cholesterol	4.00E-75	Affymetrix and Illumina [~2,600,000] (imputed)	16q13	CETP	rs173539
19060906	HDL cholesterol	1.00E-08	Affymetrix and Illumina [~2,600,000] (imputed)	19p13.2	ANGPTL4	rs2967605
19060906	LDL cholesterol	2.00E-20	Affymetrix and Illumina [~2,600,000] (imputed)	2p21	ABCG8	rs6544713
19060906	LDL cholesterol	1.00E-11	Affymetrix and Illumina [~2,600,000] (imputed)	5q33.3	TIMD4, HAVCR1	rs1501908
19060906	LDL cholesterol	2.00E-08	Affymetrix and Illumina [~2,600,000] (imputed)	12q24.31	HNF1A	rs2650000
19060906	LDL cholesterol	4.00E-09	Affymetrix and Illumina [~2,600,000] (imputed)	20q12	MAFB	rs6102059
19060906	LDL cholesterol	4.00E-08	Affymetrix and Illumina [~2,600,000] (imputed)	1p32.3	PCSK9	rs11206510
19060906	LDL cholesterol	2.00E-08	Affymetrix and Illumina [~2,600,000] (imputed)	19p13.11	NCAN, CILP2, PBX4	rs10401969
19060906	LDL cholesterol	8.00E-12	Affymetrix and Illumina [~2,600,000] (imputed)	5q13.3	HMGCR	rs3846663
19060906	LDL cholesterol	2.00E-26	Affymetrix and Illumina [~2,600,000] (imputed)	19p13.2	LDLR	rs6511720
19060906	LDL cholesterol	4.00E-27	Affymetrix and Illumina [~2,600,000] (imputed)	19q13.32	APOE, APOC1, APOC4, APOC2	rs4420638
19060906	LDL cholesterol	5.00E-29	Affymetrix and Illumina [~2,600,000] (imputed)	2p24.1	APOB	rs515135
19060906	LDL cholesterol	2.00E-42	Affymetrix and Illumina [~2,600,000] (imputed)	1p13.3	CELSR2, PSRC1, SORT1	rs12740374
19060906	Triglycerides	9.00E-12	Affymetrix and Illumina [~2,600,000] (imputed)	2p24.1	APOB	rs7557067
19060906	Triglycerides	7.00E-11	Affymetrix and Illumina [~2,600,000] (imputed)	20q13.12	PLTP	rs7679
19060906	Triglycerides	3.00E-07	Affymetrix and Illumina [~2,600,000] (imputed)	1p31.3	ANGPTL3	rs10889353
19060906	Triglycerides	4.00E-11	Affymetrix and Illumina [~2,600,000] (imputed)	19p13.11	NCAN,CILP2,PBX4	rs17216525
19060906	Triglycerides	3.00E-15	Affymetrix and Illumina [~2,600,000] (imputed)	7q11.23	MLXIPL	rs714052
19060906	Triglycerides	3.00E-19	Affymetrix and Illumina [~2,600,000] (imputed)	8q24.13	TRIB1	rs2954029
19060906	Triglycerides	2.00E-31	Affymetrix and Illumina [~2,600,000] (imputed)	2p23.3	GCKR	rs1260326
19060906	Triglycerides	2.00E-41	Affymetrix and Illumina [~2,600,000] (imputed)	8p21.3	LPL	rs12678919
19060906	Triglycerides	4.00E-62	Affymetrix and Illumina [~2,600,000] (imputed)	11q23.3	APOA1, APOC3, APOA4, APOA5	rs964184
19060906	Triglycerides	2.00E-14	Affymetrix and Illumina [~2,600,000] (imputed)	11q12.2	FADS1, FADS2, FADS3	rs174547
19060906	Triglycerides	3.00E-08	Affymetrix and Illumina [~2,600,000] (imputed)	8p23.1	XKR6, AMAC1L2	rs7819412
19060910	HDL cholesterol	2.00E-10	Illumina [329,091]	15q22.1	LIPC	rs1532085
19060910	HDL cholesterol	2.00E-07	Illumina [329,091]	17p13.3	Intergenic	rs9891572
19060910	HDL cholesterol	3.00E-08	Illumina [329,091]	16q22.1	LCAT	rs255049
19060910	HDL cholesterol	4.00E-08	Illumina [329,091]	11p11.2	NR1H3	rs7120118
19060910	HDL cholesterol	7.00E-29	Illumina [329,091]	16q13	CETP	rs3764261
19060910	LDL cholesterol	2.00E-12	Illumina [329,091]	1p13.3	CELSR2, PSRC1, SORT1	rs646776
19060910	LDL cholesterol	2.00E-07	Illumina [329,091]	Xq12	AR	rs5031002
19060910	LDL cholesterol	5.00E-08	Illumina [329,091]	19q13.32	APO cluster	rs157580
19060910	LDL cholesterol	2.00E-07	Illumina [329,091]	19p13.2	LDLR	rs11668477
19060910	LDL cholesterol	1.00E-07	Illumina [329,091]	11q12.2	FADS1, FADS2	rs174546
19060910	LDL cholesterol	3.00E-11	Illumina [329,091]	2p24.1	APOB	rs693
19060910	LDL cholesterol	2.00E-07	Illumina [329,091]	1q32.2	CR1L	rs4844614
19060910	Other metabolic traits	3.00E-22	Illumina [329,091]	1q23.2	CRP	rs2794520
19060910	Other metabolic traits	2.00E-08	Illumina [329,091]	2p24.1	APOB	rs673548
19060910	Other metabolic traits	3.00E-07	Illumina [329,091]	10q23.31	PANK1	rs11185790
19060910	Other metabolic traits	6.00E-08	Illumina [329,091]	11q21	MTNR1B	rs1447352
19060910	Other metabolic traits	1.00E-07	Illumina [329,091]	7p21.2	Intergenic	rs10244051
19060910	Other metabolic traits	6.00E-10	Illumina [329,091]	2q24.3	G6PC2, ABCB11	rs560887
19060910	Other metabolic traits	3.00E-11	Illumina [329,091]	12q24.31	LEF1	rs2650000
19060910	Other metabolic traits	4.00E-07	Illumina [329,091]	1p31.3	LEPR	rs12753193
19060910	Other metabolic traits	4.00E-07	Illumina [329,091]	15q14	Intergenic	rs2624265
19060910	Other metabolic traits	5.00E-08	Illumina [329,091]	8p21.3	LPL	rs10096633
19060910	Other metabolic traits	4.00E-10	Illumina [329,091]	2p23.3	GCKR	rs1260326
19056611	Type 2 diabetes	2.00E-17	Affymetrix [393,453]	16q12.2	FTO	rs8050136
19056611	Type 2 diabetes	9.00E-30	Affymetrix [393,453]	10q25.2	TCF7L2	rs7903146
19056611	Type 2 diabetes	5.00E-07	Affymetrix [393,453]	11p15.1	KCNJ11	rs5219
19056611	Type 2 diabetes	0.000007	Affymetrix [393,453]	8q24.11	SLC30A8	rs13266634
19056611	Type 2 diabetes	7.00E-07	Affymetrix [393,453]	9p21.3	CDKN2B	rs10811661
19056611	Type 2 diabetes	6.00E-16	Affymetrix [393,453]	10q25.2	TCF7L2	rs7903146
19056611	Type 2 diabetes	7.00E-07	Affymetrix [393,453]	6p22.3	CDKAL	rs10946398
19056611	Type 2 diabetes	1.00E-09	Affymetrix [393,453]	11p15.1	KCNJ11	rs5219
19047183	Hearing impairment	NS	Affymetrix [506,627] (pooled)	NR	NR
19043545	Serum metabolites	2.00E-09	Affymetrix [187,454]	2p14	PLEK	rs9309413
19043545	Serum metabolites	4.00E-07	Affymetrix [187,454]	3q28	FGF12	rs4453795
19043545	Serum metabolites	2.00E-07	Affymetrix [187,454]	7q31.1	Intergenic	rs10953730
19043545	Serum metabolites	1.00E-07	Affymetrix [187,454]	13q31.3	GPC5	rs17267292
19043545	Serum metabolites	5.00E-07	Affymetrix [187,454]	16p13.2	A2BP1	rs9924951
19043545	Serum metabolites	2.00E-07	Affymetrix [187,454]	15q26.1	SV2B	rs886144
19043545	Serum metabolites	1.00E-07	Affymetrix [187,454]	6q25.1	C6orf71	rs1591830
19043545	Serum metabolites	3.00E-07	Affymetrix [187,454]	6q12	Intergenic	rs9354308
19043545	Serum metabolites	1.00E-07	Affymetrix [187,454]	3p25.3	ATP2B2	rs6807064
19043545	Serum metabolites	1.00E-07	Affymetrix [187,454]	6q26	PARK2	rs992037
19043545	Serum metabolites	3.00E-09	Affymetrix [187,454]	10p11.21	ANKRD30A	rs1148259
19043545	Serum metabolites	3.00E-07	Affymetrix [187,454]	12q24.21	Intergenic	rs2194980
19043545	Serum metabolites	2.00E-07	Affymetrix [187,454]	4q13.1	Intergenic	rs10517480
19043545	Serum metabolites	5.00E-07	Affymetrix [187,454]	3q22.3	Intergenic	rs1382269
19043545	Serum metabolites	5.00E-08	Affymetrix [187,454]	11q12.2	FADS1	rs174548
19043545	Serum metabolites	1.00E-07	Affymetrix [187,454]	15q22.1	LIPC	rs4775041
18957941	Personality dimensions	9.00E-07	Affymetrix [362,129]	19q13.31	ZNF180	rs644148
18957941	Personality dimensions	0.000002	Affymetrix [362,129]	4q12	CLOCK	rs6832769
18957941	Personality dimensions	0.000006	Affymetrix [362,129]	Xp11.3	FUNDC1	rs6610953
18957941	Personality dimensions	0.000003	Affymetrix [362,129]	2p22.1	THUMPD2	rs2540226
18957941	Personality dimensions	0.000008	Affymetrix [362,129]	19q13.31	ZNF180	rs644148
19030899	Height	0.000002	Affymetrix [281,533]	9q22.23	ZNP510	rs10816533
19023125	Brain imaging in schizophrenia (interaction)	0.000004	Illumina [302,783]	3p12.3	ROBO2, ROBO1	rs9836484
19023125	Brain imaging in schizophrenia (interaction)	9.00E-08	Illumina [302,783]	5q23.2	CTXN3, SLC12A2	rs245201
19023125	Brain imaging in schizophrenia (interaction)	0.000005	Illumina [302,783]	14q32.32	TRAF3	rs10133111
19023125	Brain imaging in schizophrenia (interaction)	0.000004	Illumina [302,783]	2q37.3	GPC1	rs1574192
19023125	Brain imaging in schizophrenia (interaction)	0.000006	Illumina [302,783]	3q26.2	TNIK	rs2088885
19023125	Brain imaging in schizophrenia (interaction)	0.000009	Illumina [302,783]	6q16.2	POU3F2	rs9491640
19011631	Colorectal cancer	5.00E-09	Illumina [up to 548,586]	19q13.11	RHPN2	rs10411210
19011631	Colorectal cancer	2.00E-10	Illumina [up to 548,586]	20p12.3	Intergenic	rs961253
19011631	Colorectal cancer	1.00E-08	Illumina [up to 548,586]	16q22.1	CDH1	rs9929218
19011631	Colorectal cancer	8.00E-10	Illumina [up to 548,586]	14q22.2	BMP4	rs4444235
19010793	Brain lesion load	0.000007	Illumina [551,642]	19p13.11	CPAMD8	rs11666377
19010793	Brain lesion load	0.000007	Illumina [551,642]	6q25.3	IGF2R	rs6917747
19010793	Brain lesion load	0.000006	Illumina [551,642]	14q12	NUBPL	rs2039485
19010793	Brain lesion load	0.000004	Illumina [551,642]	2q37.1	CHRND	rs2602397
19010793	Multiple sclerosis	0.000002	Illumina [551,642]	12q12	PDZRN4	rs1458175
19010793	Multiple sclerosis	0.000003	Illumina [551,642]	3q23	SLC25A36	rs908821
19010793	Multiple sclerosis	8.00E-07	Illumina [551,642]	20p13	C20orf46	rs397020
19010793	Multiple sclerosis	0.000003	Illumina [551,642]	9p22.2	SH3GL2	rs1755289
19010793	Multiple sclerosis	0.000009	Illumina [551,642]	2p25.1	DDEF2	rs1109670
19010793	Multiple sclerosis	0.000002	Illumina [551,642]	8p23.2	CSMD1	rs1529316
19010793	Multiple sclerosis	0.000001	Illumina [551,642]	13q31.3	GPC5	rs9523762
19010793	Multiple sclerosis	0.000008	Illumina [551,642]	4q35.1	MGC45800	rs7672826
19010793	Multiple sclerosis	0.000007	Illumina [551,642]	2q14.2	EN1	rs651477
19010793	Multiple sclerosis	0.000008	Illumina [551,642]	3q24	ZIC1	rs1841770
19010793	Multiple sclerosis (age of onset)	0.000004	Illumina [551,642]	18q21.31	WDR7	rs1557351
19010793	Multiple sclerosis (age of onset)	0.000003	Illumina [551,642]	8q13.3	KCNB2	rs2116078
19010793	Multiple sclerosis (age of onset)	0.000007	Illumina [551,642]	5q33.2	SGCD	rs4704970
19010793	Multiple sclerosis (age of onset)	0.000002	Illumina [551,642]	11q14.2	RAB38	rs1386330
19010793	Multiple sclerosis (age of onset)	0.000006	Illumina [551,642]	1q25.2	C1orf125	rs12047808
19010793	Multiple sclerosis (age of onset)	0.000003	Illumina [551,642]	7q22.1	RELN	rs17157903
19010793	Multiple sclerosis (age of onset)	0.000005	Illumina [551,642]	9q21.13	RFK	rs2842483
19010793	Multiple sclerosis (age of onset)	0.000008	Illumina [551,642]	2q21.2	FLJ34870	rs1437898
19010793	Multiple sclerosis (severity)	0.000006	Illumina [551,642]	6p23	JARID2	rs6941421
19010793	Multiple sclerosis (severity)	0.000006	Illumina [551,642]	16q22.3	C16orf47	rs7191888
19010793	Multiple sclerosis (severity)	0.000006	Illumina [551,642]	11q23.3	MGC13125	rs180358
19010793	Multiple sclerosis (severity)	0.000004	Illumina [551,642]	4q13.2	CENPC1	rs10518025
19010793	Multiple sclerosis (severity)	0.000004	Illumina [551,642]	7p21.3	C1GALT1	rs10259085
19010793	Multiple sclerosis (severity)	0.000009	Illumina [551,642]	19p13.2	ACP5	rs7253363
19010793	Multiple sclerosis (severity)	0.000009	Illumina [551,642]	18q22.3	CBLN2	rs337718
19010793	Multiple sclerosis (severity)	0.000004	Illumina [551,642]	19q13.42	NLRP11	rs299175
19010793	Multiple sclerosis (severity)	0.000002	Illumina [551,642]	4q28.3	LOC132321	rs1478091
19010793	Multiple sclerosis (severity)	0.000002	Illumina [551,642]	3q25.32	FLJ16641	rs12638253
19010793	Multiple sclerosis (severity)	0.000006	Illumina [551,642]	7q31.2	MET	rs10243024
19010793	Normalized brain volume	0.000004	Illumina [551,642]	12p11.21	BICD1	rs261902
19010793	Normalized brain volume	0.000008	Illumina [551,642]	10p11.23	SVIL	rs1927457
19010793	Normalized brain volume	0.000008	Illumina [551,642]	10q25.2	MXI1	rs716595
19010793	Normalized brain volume	0.000007	Illumina [551,642]	6q21	FOXO3	rs9480865
19010793	Normalized brain volume	0.000009	Illumina [551,642]	5q35.1	KCNIP1	rs11957313
18997785	Multiple sclerosis	3.00E-10	Affymetrix [~250,000]	1p36.22	KIF1B	rs10492972
18997786	Intracranial aneurysm	4.00E-08	Illumina [289,271]	2q33.1	BOLL, PLCL1	rs700651
18997786	Intracranial aneurysm	1.00E-10	Illumina [289,271]	9q21.3	CDKN2A, CDKN2B	rs1333040
18997786	Intracranial aneurysm	1.00E-10	Illumina [289,271]	8q11.23	SOX17	rs10958409
18997786	Intracranial aneurysm	2.00E-09	Illumina [289,271]	8q11.23-q12.1	SOX17	rs9298506
19009022	Nicotine dependence	NS	Affymetrix [~600,00] (pooled)	NR	NR
18985386	Parkinson disease (familial)	7.00E-07	Illumina [328,189]	4p16.3	GAK, DGKQ	rs1564282
18987618	Amyotrophic lateral sclerosis	0.000003	Illumina [287,522]	7q36.2	DPP6	rs10260404
18980221	Attention-deficit/hyperactivity disorder	NS	Perlegen [438,784]	NR	NR
18978792	Type 1 diabetes	0.000004	Affymetrix [up to 335,565]	2p23.3	Intergenic	rs2165738
18978792	Type 1 diabetes	5.00E-12	Affymetrix [up to 335,565]	6q15	BACH2	rs11755527
18978792	Type 1 diabetes	3.00E-15	Affymetrix [up to 335,565]	15q25.1	CTSH	rs3825932
18978792	Type 1 diabetes	1.00E-40	Affymetrix [up to 335,565]	1p13.2	PTPN22	rs6679677
18978792	Type 1 diabetes	9.00E-08	Affymetrix [up to 335,565]	18p11.21	PTPN2	rs2542151
18978792	Type 1 diabetes	7.00E-13	Affymetrix [up to 335,565]	16p13.13	CLEC16A	rs12708716
18978792	Type 1 diabetes	3.00E-16	Affymetrix [up to 335,565]	12q13.2	ERBB3	rs2292239
18978792	Type 1 diabetes	6.00E-18	Affymetrix [up to 335,565]	12q24.13	C12orf30	rs17696736
18978792	Type 1 diabetes	0.000002	Affymetrix [up to 335,565]	10p15.1	IL2RA	rs12251307
18978792	Type 1 diabetes	6.00E-129	Affymetrix [up to 335,565]	6p21.32	HLA	rs9272346
18978792	Type 1 diabetes	8.00E-11	Affymetrix [up to 335,565]	2q33.2	CTLA4	rs3087243
18978792	Type 1 diabetes	2.00E-08	Affymetrix [up to 335,565]	22q13.1	C1QTNF6	rs229541
18978792	Type 1 diabetes	4.00E-09	Affymetrix [up to 335,565]	10p15.1	PRKCQ	rs947474
18978792	Type 1 diabetes	0.000003	Affymetrix [up to 335,565]	16p13.13	C16orf75, PRM3, TNP2	rs416603
18978790	Lung cancer	0.000004	Illumina [315,194]	5p15.33	TERT, CLPTM1	rs402710
18978790	Lung cancer	1.00E-15	Illumina [315,194]	15q25.1	Intergenic	rs1051730
18978787	Lung cancer	5.00E-10	Illumina [223,891]	6p21.33	BAT3,MSH5	rs3117582
18978787	Lung cancer	8.00E-09	Illumina [223,891]	5p15.33	CLPTM1L	rs401681
18978787	Lung cancer	8.00E-12	Illumina [223,891]	15q25.1	NR	rs8042374
18976728	Alzheimer's disease	0.000002	Affymetrix [484,522]	14q31.2	Intergenic	rs11159647
18976728	Alzheimer's disease	0.000006	Affymetrix [484,522]	19q13.33	CD33	rs3826656
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000009	Perlegen [378,332]	1q25.3	RGL1, GLT25D2	rs10797919
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000005	Perlegen [378,332]	14q12	Intergenic	rs1951082
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000007	Perlegen [378,332]	12q15	C12orf28	rs789560
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000002	Perlegen [378,332]	4q13.3	AMOTL1, CWC15, JMJD2D	rs10831284
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000009	Perlegen [378,332]	10p15.2	PITRM1	rs2764980
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000006	Perlegen [378,332]	9p24.1	PTPRD	rs10815798
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000005	Perlegen [378,332]	8q22.3	YWHAZ	rs931812
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000008	Perlegen [378,332]	5q31.1	C5orf15	rs1644305
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000008	Perlegen [378,332]	2q33.1	FLJ39061, FZD7	rs1521882
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000007	Perlegen [378,332]	2p12	Intergenic	rs7595103
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000004	Perlegen [378,332]	2p22.3	Intergenic	rs6733379
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000008	Perlegen [378,332]	1q23.1	ETV3L, ETV3	rs6427356
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000009	Perlegen [378,332]	1p35.2	Intergenic	rs2180233
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000002	Perlegen [378,332]	21q21.1	Intergenic	rs2826340
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000007	Perlegen [378,332]	16q23.2	PKD1L2, C16orf46	rs4889240
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000007	Perlegen [378,332]	16q22.3	PKD1L3, KIAA0174, DHODH	rs16973500
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000006	Perlegen [378,332]	18q21.31	ATP8B1	rs7236632
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000004	Perlegen [378,332]	1q42.13	LOC729257	rs701157
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000006	Perlegen [378,332]	16q21	Intergenic	rs1381102
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000009	Perlegen [378,332]	10p14	A2BP1	rs1291846
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000004	Perlegen [378,332]	15q26.2	SPATA8	rs4533251
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000005	Perlegen [378,332]	11q24.2	KIRREL3	rs1557488
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000005	Perlegen [378,332]	7q31.1	FLJ31818, GPR85	rs10229603
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000004	Perlegen [378,332]	12q21.2	PAWR	rs7297018
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000001	Perlegen [378,332]	13q33.3	LIG4, ABHD13	rs10492664
18951430	Attention-deficit/hyperactivity disorder and conduct disorder	0.000009	Perlegen [378,332]	13q12.2	GSX1, PDX1	rs9512900
18952825	Height	9.00E-10	Illumina [NR]	7p15.1	JAZF1	rs1635852
18941528	Multiple sclerosis	9.00E-11	Affymetrix [428,867] (pooled)	6p21.32	HLA-DRB1	rs3129934
18849994	Male-pattern baldness	3.00E-15	Illumina [531,695]	20p11.22	PAX1, BQ013595, BE789145	rs2180439
18849991	Male-pattern baldness	1.00E-14	Affymetrix [370,102]	20p11.22	PAX1	rs1160312
18849991	Male-pattern baldness	5.00E-11	Affymetrix [370,102]	Xq12	AR	rs6625163
18849993	Cutaneous basal cell carcinoma	4.00E-12	Illumina [304,083]	1p36.13	PADI4, PADI6,RCC2, ARHGEF10L	rs7538876
18849993	Cutaneous basal cell carcinoma	6.00E-12	Illumina [304,083]	1q42.13	RHOU	rs801114
18940312	Plasma levels of liver enzymes	2.00E-08	Affymetrix and Illumina [up to 496,032]	10q24.2q	CPN1, CHUK, ERLIN1	rs11597390
18940312	Plasma levels of liver enzymes	2.00E-10	Affymetrix and Illumina [up to 496,032]	12q24.2	HNF1A, C12orf27, C12orf43	rs1169313
18940312	Plasma levels of liver enzymes	7.00E-10	Affymetrix and Illumina [up to 496,032]	10q21.2	REEP3	rs10761779
18940312	Plasma levels of liver enzymes	8.00E-21	Affymetrix and Illumina [up to 496,032]	9q34.2	ADAMTS13	rs4962153
18940312	Plasma levels of liver enzymes	1.00E-11	Affymetrix and Illumina [up to 496,032]	6p22.2	GPLD1	rs9467160
18940312	Plasma levels of liver enzymes	4.00E-11	Affymetrix and Illumina [up to 496,032]	22q11.23	GGT1, C22orf36	rs4820599
18940312	Plasma levels of liver enzymes	2.00E-30	Affymetrix and Illumina [up to 496,032]	9p34.2	ABO	rs657152
18940312	Plasma levels of liver enzymes	7.00E-15	Affymetrix and Illumina [up to 496,032]	1p36.12	NBPF3, ALPL, RAP1GAP	rs1780324
18940312	Plasma levels of liver enzymes	5.00E-10	Affymetrix and Illumina [up to 496,032]	10q24.31	JMJD1C	rs12355784
18940312	Plasma levels of liver enzymes	8.00E-16	Affymetrix and Illumina [up to 496,032]	22q13.31	PNPLA3, SAMM50	rs2281135
18940312	Plasma levels of liver enzymes	0.000004	Affymetrix and Illumina [up to 496,032]	10q21.3	POU2F1	rs9803659
18840781	Type 1 diabetes	1.00E-06	Illumina [up to 1,000,000]	6q15	BACH2	rs3757247
18840781	Type 1 diabetes	2E-06	Illumina [up to 1,000,000]	1p22.3	EDG7	rs1983853
18840781	Type 1 diabetes	0.000003	Illumina [up to 1,000,000]	9p24.2	GLIS3	rs10758593
18840781	Type 1 diabetes	2.00E-08	Illumina [up to 1,000,000]	21q22.3	UBASH3A	rs9976767
18840781	Type 1 diabetes	4E-06	Illumina [up to 1,000,000]	15q14	RASGRP1	rs8035957
18846501	Attention-deficit/hyperactivity disorder symptoms (interaction)	0.000002	Perlegen [429,981]	13q12.3	Intergenic	rs1161463
18846501	Attention-deficit/hyperactivity disorder symptoms (interaction)	0.000008	Perlegen [429,981]	3q27.2	Intergenic	rs10049246
18846501	Attention-deficit/hyperactivity disorder symptoms (interaction)	0.000008	Perlegen [429,981]	14q24.3	Intergenic	rs2360997
18846501	Attention-deficit/hyperactivity disorder symptoms (interaction)	9.00E-07	Perlegen [429,981]	11q21	PIWIL4	rs2212361
18846501	Attention-deficit/hyperactivity disorder symptoms (interaction)	0.000009	Perlegen [429,981]	8p23.2	Intergenic	rs4875598
18846501	Attention-deficit/hyperactivity disorder symptoms (interaction)	0.000008	Perlegen [429,981]	21q21.1	Intergenic	rs2825388
18846501	Attention-deficit/hyperactivity disorder symptoms (interaction)	0.000002	Perlegen [429,981]	6p21.2	KIF6	rs4714261
18846501	Conduct disorder (interaction)	0.000005	Perlegen [429,901)	2p21	Intergenic	rs719593
18846501	Conduct disorder (interaction)	0.000007	Perlegen [429,901)	18q12.3	Intergenic	rs17664267
18846501	Conduct disorder (interaction)	0.000007	Perlegen [429,901)	1q22	RIT1	rs2282301
18846501	Conduct disorder (interaction)	0.000006	Perlegen [429,901)	10q22.3	Intergenic	rs2395528
18846501	Conduct disorder (interaction)	0.000006	Perlegen [429,901)	3p25.3	SLC6A1	rs9990174
18846501	Conduct disorder (interaction)	0.000006	Perlegen [429,901)	8p23.1	MFHAS1	rs332034
18846501	Conduct disorder (interaction)	0.000003	Perlegen [429,901)	4q23	ADH1C	rs1789891
18846501	Conduct disorder (interaction)	0.000003	Perlegen [429,901)	16p13.3	A2BP1	rs6500744
18846501	Conduct disorder (interaction)	0.000002	Perlegen [429,901)	5q21.1	Intergenic	rs13188771
18846501	Conduct disorder (interaction)	0.000009	Perlegen [429,901)	11q23.2	ZBTB16	rs17116334
18846501	Conduct disorder (interaction)	0.000008	Perlegen [429,901)	2p22.2	Intergenic	rs604381
18846501	Conduct disorder (interaction)	0.000008	Perlegen [429,901)	17q22	Intergenic	rs8073783
18846501	Conduct disorder (interaction)	0.000007	Perlegen [429,901)	4q22.1	PPM1K	rs893971
18846501	Conduct disorder (interaction)	0.000009	Perlegen [429,901)	6p15	Intergenic	rs16880441
18846501	Conduct disorder (interaction)	0.000007	Perlegen [429,901)	15q26.2	Intergenic	rs4321143
18836448	Ulcerative colitis	6.00E-18	Affymetrix [355,262]	6p21.32	HLA-DRA, BTNL2	rs9268877
18836448	Ulcerative colitis	1.00E-12	Affymetrix [355,262]	1q32.1	IL10	rs3024505
18834626	Serum urate	3.00E-60	Affymetrix and Illumina [up to 530,683]	4q22.1	ABCG2	rs2231142
18834626	Serum urate	0	Affymetrix and Illumina [up to 530,683]	4p16.1	SLC2A9	rs16890979
18834626	Serum urate	4.00E-29	Affymetrix and Illumina [up to 530,683]	6p22.2	SLC17A3	rs1165205
18991354	Ischemic stroke	2.00E-10	Illumina [310,881]	4q25	NR	rs2200733
18835860	Idiopathic pulmonary fibrosis	3.00E-08	Illumina [214,508]	5p15.33	TERT	rs2736100
18823527	Alzheimer's disease	0.000003	Illumina [561,494] (pooled)	22q13.33	CPT1B	rs727153
18823527	Alzheimer's disease	6.00E-14	Illumina [561,494] (pooled)	19q13.32	PVRL2, TOMM40, APOE	rs6859
18820697	Narcolepsy	6.00E-08	Affymetrix [249,133]	22q13.33	CPT1B	rs5770917
18821564	Attention-deficit/hyperactivity disorder	0.000003	Affymetrix [319,722]	22q13.31	Intergenic	rs9627183
18821564	Attention-deficit/hyperactivity disorder	0.000003	Affymetrix [319,722]	5p15.31	Intergenic	rs11134178
18802019	LDL cholesterol	1.00E-08	Affymetrix [~500,000]	5q13.3	HMGCR	rs7703051
18802019	LDL cholesterol	2.00E-07	Affymetrix [~500,000]	19q13.32	APOE, APOC1, APOC4, APOC2	rs4420638
18780872	Lung cancer	1.00E-08	Affymetrix [up to 722,376]	15q25.1	LOC123688, PSMA4, CHRNA3, CHRNA5, CHRNB4	rs8034191
18794855	Urinary bladder cancer	9.00E-12	Illumina [302,140]	8q24.21	MYC, BC042052	rs9642880
18794855	Urinary bladder cancer	1.00E-07	Illumina [302,140]	3q28	TP63	rs710521
18794853	Rheumatoid arthritis	1.00E-07	Illumina [818,728] Affymetrix [~340,000] (imputed)	1p36.32	MMEL1-TNFRSF14	rs3890745
18794853	Rheumatoid arthritis	9.00E-08	Illumina [818,728] Affymetrix [~340,000] (imputed)	12q13.3	KIF5A-PIP4K2C	rs1678542
18794853	Rheumatoid arthritis	8.00E-09	Illumina [818,728] Affymetrix [~340,000] (imputed)	20q13.12	CD40	rs4810485
18794853	Rheumatoid arthritis	6.00E-42	Illumina [818,728] Affymetrix [~340,000] (imputed)	1p13.2	PTPN22	rs6679677
18794853	Rheumatoid arthritis	2.00E-09	Illumina [818,728] Affymetrix [~340,000] (imputed)	6q23.3	OLIG3, TNFIP3	rs6920220
18794853	Rheumatoid arthritis	0	Illumina [818,728] Affymetrix [~340,000] (imputed)	6p21.32	HLA-DRB1	rs6457620
18794853	Rheumatoid arthritis	4E-06	Illumina [818,728] Affymetrix [~340,000] (imputed)	10p15.1	PRKCQ	rs4750316
18794853	Rheumatoid arthritis	4E-06	Illumina [818,728] Affymetrix [~340,000] (imputed)	7q21.2	CDK6	rs42041
18794853	Rheumatoid arthritis	3.00E-08	Illumina [818,728] Affymetrix [~340,000] (imputed)	9p13.3	CCL21	rs2812378
18760390	Hearing impairment	NS	Affymetrix [169,154]	NR	NR
18776929	Hip bone size	2E-06	Affymetrix [306,823]	2q33.1	PLCL1	rs7595412
18776911	Plasma level of vitamin B12	5.00E-17	Illumina [528,134]	19q13.3	FUT2	rs492602
18759275	Serum uric acid	1.00E-11	Affymetrix [361,034]	4p16.1	GLUT9, WDR1	rs16890979
18759275	Serum uric acid	0.000003	Affymetrix [361,034]	2q31.1	NR	rs4668338
18759275	Serum uric acid	2E-06	Affymetrix [361,034]	13q33.1	NR	rs4771450
18759275	Serum uric acid	0.000005	Affymetrix [361,034]	3p24.3	NR	rs6442522
18759275	Serum uric acid	8E-06	Affymetrix [361,034]	5q31.3	NR	rs3776331
18759275	Serum uric acid	0.000006	Affymetrix [361,034]	20p12.3	NR	rs6085920
18759275	Serum uric acid	4E-06	Affymetrix [361,034]	13q14.11	NR	rs17065323
18762592	Neuroticism	7.00E-07	Affymetrix [420,287]	14q21.3	MAMDC1	rs12883384
18762592	Neuroticism	0.000006	Affymetrix [420,287]	8q24.23	AK127771	rs2705293
18762592	Neuroticism	7E-06	Affymetrix [420,287]	7p21.3	NXPH1	rs2349775
18758461	Chronic lymphocytic leukemia	2.00E-20	Illumina [345,665]	6p25.3	IRF4	rs872071
18758461	Chronic lymphocytic leukemia	5.00E-12	Illumina [345,665]	15q23	Intergenic	rs7176508
18758461	Chronic lymphocytic leukemia	4.00E-12	Illumina [345,665]	11q24.1	GRAMD1B	rs735665
18758461	Chronic lymphocytic leukemia	2.00E-10	Illumina [345,665]	2q13	ACOXL,BCL2L11	rs17483466
18758461	Chronic lymphocytic leukemia	4.00E-09	Illumina [345,665]	19q13.32	PRKD2,STRN4	rs11083846
18758461	Chronic lymphocytic leukemia	6.00E-10	Illumina [345,665]	2q37.1	SP140, SP110	rs13397985
18758464	Inflammatory bowel disease	4.00E-10	Illumina [NR]	16q12.1	NOD2	rs5743289
18758464	Inflammatory bowel disease	1.00E-08	Illumina [NR]	6p21.32	HLA-DQA1	rs477515
18758464	Inflammatory bowel disease	7.00E-11	Illumina [NR]	1p31.3	IL23R	rs11209026
18758464	Inflammatory bowel disease	4.00E-12	Illumina [NR]	21q22.2	PSMG1	rs2836878
18758464	Inflammatory bowel disease	9.00E-15	Illumina [NR]	20q13.33	TNFRSF6B	rs2315008
18758464	Inflammatory bowel disease	3.00E-08	Illumina [NR]	9q32	TNFSF15	rs6478109
18729187	Lung adenocarcinoma	NS	Illumina [~318,000] (pooled)	NR	NR
18846228	Serum IgE levels	2.00E-20	Affymetrix [353,569]	1q23.2	FCER1A	rs2251746
18846228	Serum IgE levels	4.00E-08	Affymetrix [353,569]	5q31.1	RAD50	rs2040704
18711365	Bipolar disorder	9.00E-09	Affymetrix [1,769,948] imputed	10q21.2	ANK3	rs10994336
18711365	Bipolar disorder	0.000003	Affymetrix [1,769,948] imputed	9q33.3	NR	rs4130590
18711365	Bipolar disorder	4E-06	Affymetrix [1,769,948] imputed	11q14.1	NR	rs12290811
18711365	Bipolar disorder	4.00E-07	Affymetrix [1,769,948] imputed	15q14	C15orf53, RASGRP1	rs12899449
18711365	Bipolar disorder	0.000003	Affymetrix [1,769,948] imputed	2q11.2	Intergenic	rs2314398
18711365	Bipolar disorder	4E-06	Affymetrix [1,769,948] imputed	6q25.2	NR	rs17082664
18711365	Bipolar disorder	4E-06	Affymetrix [1,769,948] imputed	3p22.3	NR	rs4380451
18711365	Bipolar disorder	7.00E-08	Affymetrix [1,769,948] imputed	12q13.12	CACNA1C	rs1006737
18711365	Bipolar disorder	8E-06	Affymetrix [1,769,948] imputed	10q22.3	NR	rs703965
18711365	Bipolar disorder	7E-06	Affymetrix [1,769,948] imputed	3p26.2	NR	rs1601875
18711365	Bipolar disorder	7E-06	Affymetrix [1,769,948] imputed	18p11.32	NR	rs7226677
18711365	Bipolar disorder	0.000006	Affymetrix [1,769,948] imputed	15q25.1	NR	rs2278702
18711365	Bipolar disorder	0.000006	Affymetrix [1,769,948] imputed	11q24.2	NR	rs544368
18711365	Bipolar disorder	0.000006	Affymetrix [1,769,948] imputed	9q31.3	NR	rs7042161
18711365	Bipolar disorder	0.000006	Affymetrix [1,769,948] imputed	1p21.2	NR	rs1948368
18711365	Bipolar disorder	0.000005	Affymetrix [1,769,948] imputed	3p24.3	NR	rs11720452
18711365	Bipolar disorder	0.000005	Affymetrix [1,769,948] imputed	14q11.2	NR	rs12436436
18711365	Bipolar disorder	0.000005	Affymetrix [1,769,948] imputed	14q13.1	NR	rs8015959
18711365	Bipolar disorder	0.000005	Affymetrix [1,769,948] imputed	3p24.3	NR	rs3821396
18711365	Bipolar disorder	4E-06	Affymetrix [1,769,948] imputed	9p13.3	NR	rs216345
18711365	Bipolar disorder	4E-06	Affymetrix [1,769,948] imputed	15q14	NR	rs16966460
18685109	TP53 carriage	Pending	Affymetrix [3,884 CNVs]	Pending	Pending
18690218	Sarcoidosis	NS	Affymetrix [375,771]	NR	NR
18677312	Systemic lupus erythematosus	3.00E-12	Affymetrix [313,238]	6q23.3	TNFAIP3	rs5029939
18677312	Systemic lupus erythematosus	0.000003	Affymetrix [313,238]	10q11.22	c10orf64	rs11101442
18677312	Systemic lupus erythematosus	8E-06	Affymetrix [313,238]	4q28.3	Intergenic	rs2313132
18677312	Systemic lupus erythematosus	8.00E-11	Affymetrix [313,238]	2q32.3	STAT4	rs3821236
18677312	Systemic lupus erythematosus	2E-06	Affymetrix [313,238]	16p11.2	ITGAM	rs11150610
18677312	Systemic lupus erythematosus	2.00E-08	Affymetrix [313,238]	8p23.1	BLK	rs2618476
18677312	Systemic lupus erythematosus	8E-06	Affymetrix [313,238]	17p12	Intergenic	rs12949531
18677312	Systemic lupus erythematosus	0.000009	Affymetrix [313,238]	2p16.3	Intergenic	rs17039212
18668548	Rheumatoid arthritis	0.000006	Illumina [299,918]	18q23	SALL3	rs2002842
18668548	Rheumatoid arthritis	1.00E-09	Illumina [299,918]	6p21.32	HLA-DQA1, HLA-DQA2	rs6457617
18677311	Schizophrenia	2.00E-07	Affymetrix [362,532]	2q32.1	ZNF804A	rs1344706
18677311	Schizophrenia	0.000003	Affymetrix [362,532]	11p14.1	Intergenic	rs1602565
18677311	Schizophrenia	0.000006	Affymetrix [362,532]	16p13.12	Intergenic	rs7192086
18660810	Restless legs syndrome	6.00E-09	Affymetrix [208,733]	9p24.1	PTPRD	rs1975197
18660810	Restless legs syndrome	6.00E-10	Affymetrix [208,733]	9p23	PTPRD	rs4626664
18650507	Myopathy	2.00E-09	Illumina [316,184]	12p12.1	SLCO1B1	rs4149056
18723019	Crohn's disease and Sarcoidosis (combined)	0.000004	Affymetrix [83,360]	10p12.2	C10orf67	rs1398024
18615156	Treatment response to TNF antagonists	2.00E-07	Illumina [283,348]	20q12	MAFB	rs6028945
18615156	Treatment response to TNF antagonists	2E-06	Illumina [283,348]	7q21.3	PON1	rs854555
18615156	Treatment response to TNF antagonists	4E-06	Illumina [283,348]	4p15.1	CENTD1	rs437943
18615156	Treatment response to TNF antagonists	3.00E-07	Illumina [283,348]	6q26	QKI	rs10945919
18615156	Treatment response to TNF antagonists	4E-06	Illumina [283,348]	2q24.3	LASS6	rs13393173
18615156	Treatment response to TNF antagonists	0.000005	Illumina [283,348]	1p22.3	LMO4	rs983332
18615156	Treatment response to TNF antagonists	0.000003	Illumina [283,348]	20p11.21	CST5	rs6138150
18615156	Treatment response to TNF antagonists	5.00E-07	Illumina [283,348]	9p21.2	IFNK	rs7046653
18604267	Soluble ICAM-1	5.00E-29	Illumina [336,108]	9q34.2	ABO	rs507666
18604267	Soluble ICAM-1	3.00E-10	Illumina [336,108]	19p13.2	ICAM1	rs281437
18604267	Soluble ICAM-1	5.00E-25	Illumina [336,108]	19p13.2	ICAM1	rs5498
18604267	Soluble ICAM-1	4.00E-47	Illumina [336,108]	19p13.2	ICAM1	rs1799969
18601904	Subarachnoid aneurysmal hemorrhage	Pending	Illumina [317,503]	Pending	Pending
18594024	Osteonecrosis of the jaw	1.00E-06	Affymetrix [339,972]	10q23.33	CYP2C8	rs1934951
18591461	Response to diuretic therapy	0.000006	Affymetrix [up to 102,334]	12q15	LYZ, YEATS4, FRS2	rs317689,rs315135,rs7297610
18587394	Crohn's disease	2.00E-13	Affymetrix and Illumina [635,547] (imputed)	13q14.11	Unknown	rs3764147
18587394	Crohn's disease	7.00E-12	Affymetrix and Illumina [635,547] (imputed)	17q21.2	STAT3	rs744166
18587394	Crohn's disease	2.00E-10	Affymetrix and Illumina [635,547] (imputed)	6q21	Unknown	rs7746082
18587394	Crohn's disease	1.00E-12	Affymetrix and Illumina [635,547] (imputed)	6q27	CCR6	rs2301436
18587394	Crohn's disease	4.00E-13	Affymetrix and Illumina [635,547] (imputed)	5q33.3	IL12B	rs10045431
18587394	Crohn's disease	2.00E-09	Affymetrix and Illumina [635,547] (imputed)	10p11.21	Intergenic	rs17582416
18587394	Crohn's disease	3.00E-09	Affymetrix and Illumina [635,547] (imputed)	9p24.1	JAK2	rs10758669
18587394	Crohn's disease	5.00E-09	Affymetrix and Illumina [635,547] (imputed)	8q24.13	Intergenic	rs1551398
18587394	Crohn's disease	5.00E-09	Affymetrix and Illumina [635,547] (imputed)	7p12.2	Intergenic	rs1456893
18587394	Crohn's disease	9.00E-10	Affymetrix and Illumina [635,547] (imputed)	6p22.3	CDKAL1	rs6908425
18587394	Crohn's disease	1.00E-11	Affymetrix and Illumina [635,547] (imputed)	1q32.1	Intergenic	rs11584383
18587394	Crohn's disease	2.00E-09	Affymetrix and Illumina [635,547] (imputed)	1q24.3	Intergenic	rs9286879
18587394	Crohn's disease	1.00E-09	Affymetrix and Illumina [635,547] (imputed)	1q23.2	ITLN1	rs2274910
18587394	Crohn's disease	1.00E-08	Affymetrix and Illumina [635,547] (imputed)	1p13.2	PTPN22	rs2476601
18587394	Crohn's disease	4.00E-20	Affymetrix and Illumina [635,547] (imputed)	10q21.2	ZNF365	rs10995271
18587394	Crohn's disease	5.00E-17	Affymetrix and Illumina [635,547] (imputed)	18p11.21	PTPN2	rs2542151
18587394	Crohn's disease	3.00E-24	Affymetrix and Illumina [635,547] (imputed)	16q12.1	NOD2	rs2066847
18587394	Crohn's disease	3.00E-16	Affymetrix and Illumina [635,547] (imputed)	10q24.2	NKX2-3	rs11190140
18587394	Crohn's disease	3.00E-10	Affymetrix and Illumina [635,547] (imputed)	9q32	TNFSF15	rs4263839
18587394	Crohn's disease	3.00E-16	Affymetrix and Illumina [635,547] (imputed)	5q33.1	IRGM	rs11747270
18587394	Crohn's disease	2.00E-18	Affymetrix and Illumina [635,547] (imputed)	5q31.1	Intergenic	rs2188962
18587394	Crohn's disease	7.00E-27	Affymetrix and Illumina [635,547] (imputed)	5p13.1	PTGER4	rs4613763
18587394	Crohn's disease	1.00E-12	Affymetrix and Illumina [635,547] (imputed)	3p21.31	MST1	rs3197999
18587394	Crohn's disease	2.00E-32	Affymetrix and Illumina [635,547] (imputed)	2q37.1	ATG16L1	rs3828309
18587394	Crohn's disease	7.00E-63	Affymetrix and Illumina [635,547] (imputed)	1p31.3	IL23R	rs11465804
18587394	Crohn's disease	1.00E-09	Affymetrix and Illumina [635,547] (imputed)	21q22.3	ICOSLG	rs762421
18587394	Crohn's disease	7.00E-09	Affymetrix and Illumina [635,547] (imputed)	21q21.1	Intergenic	rs1736135
18587394	Crohn's disease	5.00E-09	Affymetrix and Illumina [635,547] (imputed)	17q12	ORMDL3	rs2872507
18587394	Crohn's disease	3.00E-10	Affymetrix and Illumina [635,547] (imputed)	12q12	LRRK2, MUC19	rs11175593
18587394	Crohn's disease	1.00E-09	Affymetrix and Illumina [635,547] (imputed)	11q13.5	C11orf30	rs7927894
18576341	Juvenile idiopathic arthritis	2.00E-10	Illumina [524,684]	6p21.32	HLA-DRB1	rs2395148
18451265	Fasting plasma glucose	4.00E-23	Illumina [392,935]	2q24.3	G6PC2	rs560887
18535201	Warfarin maintenance dose	9.00E-07	Illumina [538,629]	12p13.33	CACNA1C	rs216013
18535201	Warfarin maintenance dose	5.00E-34	Illumina [538,629]	16p11.2	VKORC1	rs10871454
18535201	Warfarin maintenance dose	6.00E-12	Illumina [538,629]	10q23.33	CYP2C9	rs4086116
18521185	Fasting plasma glucose	4.00E-07	Illumina [315,635]	2q24.3	G6PC2,ABCB11	rs563694
18519826	Smoking cessation	NS	Affymetrix [~500,000] (pooled)	NR	NR
18521090	Response to iloperidone treatment (PANSS-T score)	NS	Affymetrix [334,563]	NR	NR
18521091	Response to iloperidone treatment (QT prolongation)	2E-06	Affymetrix [339,272]	14q12	NUBPL	rs7142881
18521091	Response to iloperidone treatment (QT prolongation)	0.000003	Affymetrix [339,272]	18q12.2	BRUNOL4	rs4799915
18521091	Response to iloperidone treatment (QT prolongation)	0.000003	Affymetrix [339,272]	2q31.3	CERKL	rs993648
18521091	Response to iloperidone treatment (QT prolongation)	2E-06	Affymetrix [339,272]	15q26.1	SLCO3A1	rs3924426
18521091	Response to iloperidone treatment (QT prolongation)	0.000003	Affymetrix [339,272]	4q32.3	PALLD	rs17054392
18521091	Response to iloperidone treatment (QT prolongation)	2E-06	Affymetrix [339,272]	10q23.1	NRG3	rs4933824
18488026	Melanoma	1.00E-15	Illumina [535,150] (pooled)	20q11.22	CDC91L1	rs910873
18488028	Blond vs. brown hair	4.00E-30	Illumina [316,515]	11q13.2	TPCN2	rs35264875
18488028	Blue vs. green eyes	6.00E-17	Illumina [316,515]	9p23	TYRP1	rs1408799
18488028	Burning and freckling	6.00E-37	Illumina [316,515]	20q11.22	ASIP	rs1015362,rs4911414
18488028	Freckles	8.00E-29	Illumina [316,515]	20q11.22	ASIP	rs1015362,rs4911414
18488028	Red vs. non-red hair	3.00E-09	Illumina [316,515]	20q11.22	ASIP	rs1015362,rs4911414
18488028	Skin sensitivity to sun	2.00E-24	Illumina [316,515]	20q11.22	ASIP	rs1015362,rs4911414
18483556	Black vs. blond hair color	5.00E-11	Illumina [528,173]	15q13.1	Intergenic	rs8033165
18483556	Black vs. blond hair color	2.00E-24	Illumina [528,173]	15q13.1	OCA2	rs11855019
18483556	Black vs. blond hair color	1.00E-17	Illumina [528,173]	5p13.3	MATP	rs28777
18483556	Black vs. blond hair color	6.00E-08	Illumina [528,173]	6p25.3	EXOC2	rs6918152
18483556	Black vs. blond hair color	7.00E-127	Illumina [528,173]	6p25.3	IRF4	rs12203592
18483556	Black vs. blond hair color	4.00E-103	Illumina [528,173]	15q13.1	HERC2	rs12913832
18483556	Black vs. blond hair color	8.00E-21	Illumina [528,173]	14q32.12	SLC24A4	rs12896399
18483556	Black vs. red hair color	2.00E-12	Illumina [528,173]	15q13.1	Intergenic	rs8033165
18483556	Black vs. red hair color	2.00E-23	Illumina [528,173]	16q24.3	MC1R	rs258322
18483556	Black vs. red hair color	9.00E-14	Illumina [528,173]	5p13.3	MATP	rs28777
18483556	Black vs. red hair color	1.00E-77	Illumina [528,173]	15q13.1	HERC2	rs12913832
18483556	Black vs. red hair color	5.00E-07	Illumina [528,173]	6p25.3	EXOC2	rs6918152
18483556	Black vs. red hair color	9.00E-28	Illumina [528,173]	6p25.3	IRF4	rs12203592
18483556	Black vs. red hair color	6.00E-20	Illumina [528,173]	15q13.1	OCA2	rs11855019
18463370	Neuroblastoma	9.00E-15	Illumina [464,934]	6p22.3	FLJ22536, FLJ44180	rs6939340
18464913	Protein quantitative trait loci	7.00E-40	Illumina [496,032]	9q34.2	ABO	rs505922
18464913	Protein quantitative trait loci	3.00E-07	Illumina [496,032]	17p13.1	SHBG	rs6761
18464913	Protein quantitative trait loci	0.000006	Illumina [496,032]	1q23.2	CRP	rs12093699
18464913	Protein quantitative trait loci	7E-06	Illumina [496,032]	2q13	IL1RN	rs6761276
18464913	Protein quantitative trait loci	0.000006	Illumina [496,032]	2p15	LOC51057	rs11683229
18464913	Protein quantitative trait loci	5.00E-07	Illumina [496,032]	2p12	CTNNA2	rs11695685
18464913	Protein quantitative trait loci	4E-06	Illumina [496,032]	2q23.1	EPC2	rs10191411
18464913	Protein quantitative trait loci	1.00E-06	Illumina [496,032]	5q35.1	DOCK2	rs169082
18464913	Protein quantitative trait loci	3.00E-07	Illumina [496,032]	6q11.1	KHDRBS2	rs6455128
18464913	Protein quantitative trait loci	7.00E-13	Illumina [496,032]	11q23.1	IL18	rs2250417
18464913	Protein quantitative trait loci	2.00E-07	Illumina [496,032]	22q11.23	GGT1	rs5751901
18464913	Protein quantitative trait loci	4.00E-10	Illumina [496,032]	6q26	LPA	rs7770628
18464913	Protein quantitative trait loci	4.00E-21	Illumina [496,032]	17q12	CCL4L2	rs4796217
18464913	Protein quantitative trait loci	2.00E-57	Illumina [496,032]	1q21.3	IL6R	rs4129267
18464913	Protein quantitative trait loci	0.000006	Illumina [496,032]	10p12.33	CACNB2	rs7076247
18464913	Protein quantitative trait loci	8.00E-07	Illumina [496,032]	9q31.2	TMEM38B	rs4742971
18464913	Protein quantitative trait loci	0.000003	Illumina [496,032]	9q22.2	GADD45G,DIRAS2	rs2081670
18464913	Protein quantitative trait loci	0.000006	Illumina [496,032]	8q24.21	FAM49B	rs10092658
18464913	Protein quantitative trait loci	8.00E-07	Illumina [496,032]	8q21.11	GDAP1,PI15	rs6472866
18464913	Protein quantitative trait loci	1.00E-06	Illumina [496,032]	7p21.3	NXPH1	rs1285407
18464913	Protein quantitative trait loci	1.00E-06	Illumina [496,032]	6q24.3	SASH1	rs6930337
18464913	Protein quantitative trait loci	1.00E-06	Illumina [496,032]	6q23.2	EYA4	rs9402515
18464913	Protein quantitative trait loci	2E-06	Illumina [496,032]	6q22.31	GJA1	rs4541776
18464913	Protein quantitative trait loci	1.00E-06	Illumina [496,032]	12q24.33	GPR133	rs10466868
18464913	Protein quantitative trait loci	1.00E-07	Illumina [496,032]	12q24.11	ATP2A2	rs11065611
18464913	Protein quantitative trait loci	1.00E-10	Illumina [496,032]	12q12	PDZRN4,CNTN1	rs1880887
18464913	Protein quantitative trait loci	7.00E-07	Illumina [496,032]	12p12.3	EPS8	rs17415853
18464913	Protein quantitative trait loci	1.00E-06	Illumina [496,032]	11q24.2	KIRREL3	rs1939992
18464913	Protein quantitative trait loci	6.00E-09	Illumina [496,032]	11q23.3	PAFAH1B2	rs7112513
18464913	Protein quantitative trait loci	8E-06	Illumina [496,032]	11q14.1	DLG2	rs3885683
18464913	Protein quantitative trait loci	1.00E-06	Illumina [496,032]	11p15.5	KCNQ1	rs2237878
18464913	Protein quantitative trait loci	0.000003	Illumina [496,032]	10p11.21	FZD8,ANKRD30A	rs1779876
18464913	Protein quantitative trait loci	0.000003	Illumina [496,032]	18q12.1	DSC3	rs2729409
18464913	Protein quantitative trait loci	2.00E-07	Illumina [496,032]	18q11.2	OSBPL1A	rs9635963
18464913	Protein quantitative trait loci	4.00E-07	Illumina [496,032]	17q25.3	C17orf62	rs9303029
18464913	Protein quantitative trait loci	8.00E-09	Illumina [496,032]	17p12	HS3ST3B1	rs3848445
18464913	Protein quantitative trait loci	5.00E-07	Illumina [496,032]	16q23.2	BCM01	rs4889294
18464913	Protein quantitative trait loci	0.000003	Illumina [496,032]	15q21.1	DUT	rs11637235
18464913	Protein quantitative trait loci	5.00E-07	Illumina [496,032]	15q15.2	CDAN1	rs16957063
18464913	Protein quantitative trait loci	4E-06	Illumina [496,032]	13q12.2	SACS	rs4770433
18464913	Protein quantitative trait loci	1.00E-07	Illumina [496,032]	13q12.11	FGF3	rs17369571
18464913	Protein quantitative trait loci	4.00E-07	Illumina [496,032]	19p13.2	ANGPTL6	rs8109578
18464913	Protein quantitative trait loci	4E-06	Illumina [496,032]	6p21.33	HLA-C	rs9461688
18464913	Protein quantitative trait loci	4E-06	Illumina [496,032]	3p12.3	ROBO1	rs9834373
18464913	Protein quantitative trait loci	7E-06	Illumina [496,032]	2p11.2	SH2D6	rs7577642
18464913	Protein quantitative trait loci	1.00E-06	Illumina [496,032]	2p13.3	DYSF	rs2900976
18464913	Protein quantitative trait loci	7.00E-07	Illumina [496,032]	1q21.1	CHD1L	rs4950322
18464913	Protein quantitative trait loci	2.00E-07	Illumina [496,032]	1q21.1	CHD1L	rs4950322
18464913	Protein quantitative trait loci	0.000003	Illumina [496,032]	1p21.1	COL11A	rs10874639
18463975	Breast cancer	4.00E-07	Affymetrix [200,220]	2q37.1	GLG1	rs10871290
18471798	Knee osteoarthritis	0.000003	Illumina [413,461]	1q31.1	PTGS2, PLA2G4A	rs4140564
18471798	Knee osteoarthritis	0.000006	Illumina [413,461]	2q33.3	PARD3B	rs1207421
18454146	Waist circumference and related phenotypes	2.00E-09	Illumina [308,067]	18q21.32	MC4R	rs12970134
18454146	Waist circumference and related phenotypes	1.00E-27	Illumina [308,067]	16q13	CETP	rs3764261
18454146	Waist circumference and related phenotypes	0.000005	Illumina [308,067]	8p21.3	LPL	rs2083637
18454146	Waist circumference and related phenotypes	4.00E-08	Illumina [308,067]	2p23.3	GCKR	rs1260326
18454148	Body mass index	4.00E-08	Affymetrix [344,883]	16q12.2	FTO	rs1121980
18454148	Body mass index	3.00E-15	Affymetrix [344,883]	18q21.32	MC4R	rs17782313
18449908	Alzheimer's disease	NS	Affymetrix [469,218]	NR	NR
18455228	Bone mineral density	8.00E-10	Illumina [314,075]	8q24.12	TNFRSF11B	rs4355801
18455228	Bone mineral density	6.00E-12	Illumina [314,075]	11q13.2	LRP5	rs3736228
18445777	Bone mineral density (hip)	5.00E-16	Illumina [301,019]	1p36.12	ZBTB40	rs7524102
18445777	Bone mineral density (hip)	3.00E-11	Illumina [301,019]	8q24.12	OPG	rs6993813
18445777	Bone mineral density (hip)	1.00E-06	Illumina [301,019]	18q21.33	RANK	rs3018362
18445777	Bone mineral density (hip)	2.00E-07	Illumina [301,019]	6q25.1	ESR1, C6orf97	rs4870044
18445777	Bone mineral density (hip)	2.00E-08	Illumina [301,019]	13q14.11	RANKL	rs9594738
18445777	Bone mineral density (hip)	5.00E-09	Illumina [301,019]	6q25.1	ESR1	rs1038304
18445777	Bone mineral density (spine)	8.00E-07	Illumina [301,019]	2p16.2	SPTBN1	rs11898505
18445777	Bone mineral density (spine)	2.00E-21	Illumina [301,019]	13q14.11	RANKL	rs9594759
18445777	Bone mineral density (spine)	7.00E-15	Illumina [301,019]	8q24.12	OPG	rs6469804
18445777	Bone mineral density (spine)	4.00E-11	Illumina [301,019]	6q25.1	ESR1, C6orf97	rs1038304
18445777	Bone mineral density (spine)	9.00E-09	Illumina [301,019]	1p36.12	ZBTB40	rs7524102
18445777	Bone mineral density (spine)	1.00E-07	Illumina [301,019]	6p21.32	MHC, C6orf10	rs3130340
18445777	Bone mineral density (spine)	2.00E-11	Illumina [301,019]	6p25.1	ESR1	rs4870044
18445777	Bone mineral density (spine)	2.00E-08	Illumina [301,019]	6q25.1	ESR1, C6orf97	rs1999805
18369103	Schizophrenia	Pending	Illumina [~550,000]	Pending	Pending
18439552	C-reactive protein	2.00E-08	Illumina [317,000]	12q24.31	HNF1A	rs1169310
18439552	C-reactive protein	1.00E-07	Illumina [317,000]	19q13.32	APOE	rs2075650
18439552	C-reactive protein	7E-06	Illumina [317,000]	1q23.2	CRP	rs11265260
18439548	C-reactive protein	7.00E-21	Illumina [336,108]	1p31.3	LEPR	rs1892534
18439548	C-reactive protein	1.00E-10	Illumina [336,108]	12q23.2	Unknown	rs10778213
18439548	C-reactive protein	2.00E-08	Illumina [336,108]	1q21.3	IL6R	rs8192284
18439548	C-reactive protein	6.00E-28	Illumina [336,108]	1q23.2	CRP	rs3091244
18439548	C-reactive protein	9.00E-21	Illumina [336,108]	19q13.32	APOE	rs769449
18439548	C-reactive protein	7.00E-15	Illumina [336,108]	2p23.3	GCKR	rs780094
18439548	C-reactive protein	7.00E-17	Illumina [336,108]	12q24.31	HNF1A	rs7310409
18403759	YKL-40 levels	1.00E-13	Affymetrix [290,325]	1q32.1	CHI3L1	rs4950928
18391951	Height	1.00E-27	Illumina and Affymetrix [up to 304,226]	3q23	ZBTB38	rs6763931
18391951	Height	7.00E-15	Illumina and Affymetrix [up to 304,226]	7p22.2	GNA12	rs798544
18391951	Height	5.00E-14	Illumina and Affymetrix [up to 304,226]	6q24.1	GPR126	rs3748069
18391951	Height	2.00E-11	Illumina and Affymetrix [up to 304,226]	6p24.3	BMP6	rs12198986
18391951	Height	3.00E-08	Illumina and Affymetrix [up to 304,226]	1q24.3	DNM3	rs678962
18391951	Height	6.00E-11	Illumina and Affymetrix [up to 304,226]	2p16.1	EFEMP1, PNPT1	rs3791679
18391951	Height	6.00E-10	Illumina and Affymetrix [up to 304,226]	6p22.1	Histone class 1,Butyrophilin genes	rs10946808
18391951	Height	1.00E-08	Illumina and Affymetrix [up to 304,226]	6p21.31	HMGA1, LBH	rs1776897
18391951	Height	1.00E-07	Illumina and Affymetrix [up to 304,226]	17q22	NOG, DGKE, TRIM25, COIL, RISK	rs4794665
18391951	Height	2.00E-09	Illumina and Affymetrix [up to 304,226]	17q11.2	CRLF3, ATAD5, CENTA2, RNF135	rs3760318
18391951	Height	3.00E-08	Illumina and Affymetrix [up to 304,226]	15q26.3	ADAMTS17	rs4533267
18391951	Height	2.00E-16	Illumina and Affymetrix [up to 304,226]	12q14.3	HMGA2	rs8756
18391951	Height	2.00E-08	Illumina and Affymetrix [up to 304,226]	9q31.2	ZNF462	rs4743034
18391951	Height	5.00E-08	Illumina and Affymetrix [up to 304,226]	8q21.11	PXMP3, ZFHX4	rs7846385
18391951	Height	7.00E-08	Illumina and Affymetrix [up to 304,226]	8q12.1	PLAG1, MOS, CHCHD7,RDHE2, RPS20,LYN, TGS1, PENK	rs10958476
18391951	Height	1.00E-08	Illumina and Affymetrix [up to 304,226]	7q21.2	CDK6, PEX1, GATAD1, ERVWE1	rs2282978
18391951	Height	4.00E-08	Illumina and Affymetrix [up to 304,226]	6p21.31	ANKS1A, TCP11, ZNF76, DEF6,SCUBE3	rs4713858
18391951	Height	2.00E-07	Illumina and Affymetrix [up to 304,226]	9q32	COL27A1	rs946053
18391951	Height	9.00E-07	Illumina and Affymetrix [up to 304,226]	9q22.1	SPIN1, CCRK	rs2814828
18391951	Height	0.000006	Illumina and Affymetrix [up to 304,226]	6q22.33-6q23.1	L3MBTL3, SAMD3	rs6899976
18391951	Height	6.00E-07	Illumina and Affymetrix [up to 304,226]	6q22.32	C6orf173	rs1490388
18391951	Height	4E-06	Illumina and Affymetrix [up to 304,226]	6q21	PPIL6, CD164, SMPD2,MNICAL1,ZBTB24	rs9487094
18391951	Height	8.00E-07	Illumina and Affymetrix [up to 304,226]	6q21	LIN28B, HACE1, BVES, POPDC3	rs314268
18391951	Height	8E-06	Illumina and Affymetrix [up to 304,226]	6p12.3	SUPT3H, RUNX2	rs9395066
18391951	Height	7.00E-07	Illumina and Affymetrix [up to 304,226]	6p22.3	NUP153, CAP2, KIF13A	rs12199222
18391951	Height	8E-06	Illumina and Affymetrix [up to 304,226]	5q31.1	PITX1, PCBD2, CATSPER3, TXNDC15,DDX46, CAMLG	rs31198
18391951	Height	1.00E-06	Illumina and Affymetrix [up to 304,226]	19p13.2	ADAMTS10, MYO1F, PRAM1, OR2Z1	rs7249094
18391951	Height	7.00E-07	Illumina and Affymetrix [up to 304,226]	17q23.3	MAP3K3, WDR68, LYK5, MT1F	rs7209435
18391951	Height	8.00E-07	Illumina and Affymetrix [up to 304,226]	16q24.1	ZDHHC7, CRISPLD2, USP10	rs2326458
18391951	Height	9.00E-07	Illumina and Affymetrix [up to 304,226]	15q25.2	ADAMTSL3, SH3GL3	rs2554380
18391951	Height	8E-06	Illumina and Affymetrix [up to 304,226]	13q14.3	DLEU7	rs1239947
18391951	Height	2.00E-07	Illumina and Affymetrix [up to 304,226]	12q22	SOCS2, MRPL42, CRADD, UBE2N	rs3825199
18391951	Height	0.000003	Illumina and Affymetrix [up to 304,226]	12q15	LYZ,YEATS4,FRS2,CPSF6,CCT2,LRRC10	rs11177669
18391951	Height	2E-06	Illumina and Affymetrix [up to 304,226]	12p12.2	PDE3A, SLCO1C1, SLCO1B3	rs11611208
18391951	Height	2E-06	Illumina and Affymetrix [up to 304,226]	12p13.2	ETV6	rs2187642
18391951	Height	1.00E-10	Illumina and Affymetrix [up to 304,226]	14q23.12	TRIP11, FBLN5, ATXN3, CPSF2	rs7153027
18391951	Height	8.00E-07	Illumina and Affymetrix [up to 304,226]	20q11.22	UQCC, GDF5, CEP250, EIF6, MMP24	rs6088792
18391951	Height	0.000003	Illumina and Affymetrix [up to 304,226]	Xq21.1	ITM2A	rs1474563
18391951	Height	0.000006	Illumina and Affymetrix [up to 304,226]	22q11.23	BCR, GNAZ, RTDR1, IGLL1	rs5751614
18391951	Height	2E-06	Illumina and Affymetrix [up to 304,226]	4q21.21	BMP3, PRKG2, RASGEF1B	rs710841
18391951	Height	7E-06	Illumina and Affymetrix [up to 304,226]	3q26.2	GOLIM4, SERPINI1	rs4345115
18391951	Height	1.00E-06	Illumina and Affymetrix [up to 304,226]	2q37.1	NPPC, DIS3L2, COPS7B, PDE6D, PTMA	rs749052
18391951	Height	1.00E-06	Illumina and Affymetrix [up to 304,226]	2q35	IHH, CRYBA2, FEV, SLC23A3, TUBA1	rs1052483
18391951	Height	8.00E-07	Illumina and Affymetrix [up to 304,226]	2p23.3	ADCY3, RBJ, POMC, DNMT3A, DTNB	rs6733301
18391951	Height	2.00E-08	Illumina and Affymetrix [up to 304,226]	20p12.3	BMP2	rs967417
18391951	Height	4.00E-09	Illumina and Affymetrix [up to 304,226]	18q11.2	CABLES1, RBBP8, C18orf45	rs4800148
18391951	Height	6.00E-08	Illumina and Affymetrix [up to 304,226]	17q23.2	BCAS3, NACA2, TBX2, TBX4	rs757608
18391951	Height	3.00E-08	Illumina and Affymetrix [up to 304,226]	6p21.32	HLA class III	rs185819
18391951	Height	1.00E-10	Illumina and Affymetrix [up to 304,226]	4p15.32	LCORL, NCAPG	rs6830062
18391951	Height	8.00E-09	Illumina and Affymetrix [up to 304,226]	1q25.3	C1orf19,GLT25D2	rs2274432
18391951	Height	1.00E-10	Illumina and Affymetrix [up to 304,226]	1q21.2	Histone class 2A,MTMR11, SV2A, SF3B4	rs11205277
18391951	Height	1.00E-11	Illumina and Affymetrix [up to 304,226]	4q31.22	HHIP	rs1812175
18391950	Height	8.00E-22	Affymetrix and Illumina [2,260,683] (imputed)	3q23	ZBTB38	rs724016
18391950	Height	4.00E-17	Affymetrix and Illumina [2,260,683] (imputed)	6q22.1	HIST1H1D	rs10946808
18391950	Height	1.00E-11	Affymetrix and Illumina [2,260,683] (imputed)	4q31.22	HHIP	rs1492820
18391950	Height	2E-06	Affymetrix and Illumina [2,260,683] (imputed)	17q22	ANKFN1	rs12449568
18391950	Height	1.00E-06	Affymetrix and Illumina [2,260,683] (imputed)	9q33.1	PAPPA	rs7869550
18391950	Height	8.00E-07	Affymetrix and Illumina [2,260,683] (imputed)	9q34.11	FUBP3	rs7466269
18391950	Height	3.00E-07	Affymetrix and Illumina [2,260,683] (imputed)	7q36.3	WDR60	rs2730245
18391950	Height	4.00E-07	Affymetrix and Illumina [2,260,683] (imputed)	7q21.2	CDK6	rs2040494
18391950	Height	4.00E-07	Affymetrix and Illumina [2,260,683] (imputed)	8q12.1	CHCHD7,RDHE2	rs9650315
18391950	Height	6.00E-08	Affymetrix and Illumina [2,260,683] (imputed)	15q25.2	SH3GL3,ADAMTSL3	rs2562784
18391950	Height	3.00E-08	Affymetrix and Illumina [2,260,683] (imputed)	19p13.3	DOT1L	rs12986413
18391950	Height	1.00E-08	Affymetrix and Illumina [2,260,683] (imputed)	6q21	LIN28B	rs314277
18391950	Height	1.00E-16	Affymetrix and Illumina [2,260,683] (imputed)	20q11.22	GDF5,UQCC	rs6060369
18391950	Height	3.00E-20	Affymetrix and Illumina [2,260,683] (imputed)	12q14.3	HMGA2	rs1042725
18391950	Height	8E-06	Affymetrix and Illumina [2,260,683] (imputed)	14q13.3	NKX2-1	rs17104630
18391950	Height	0.000005	Affymetrix and Illumina [2,260,683] (imputed)	16p13.3	RAB40C	rs763014
18391950	Height	6.00E-10	Affymetrix and Illumina [2,260,683] (imputed)	14q32.12	TRIP11,ATXN3	rs8007661
18391950	Height	2.00E-18	Affymetrix and Illumina [2,260,683] (imputed)	6q24.3	GPR126	rs4896582
18391952	Height	2.00E-24	Affymetrix [402,951]	3q23	ZBTB38	rs6440003
18391952	Height	4.00E-11	Affymetrix [402,951]	9q22.32	PTCH1	rs10512248
18391952	Height	7.00E-08	Affymetrix [402,951]	3q22.2	ANAPC13,CEP63	rs10935120
18391952	Height	2.00E-08	Affymetrix [402,951]	2q35	IHH	rs6724465
18391952	Height	2.00E-08	Affymetrix [402,951]	15q25.2	ADAMTSL3	rs10906982
18391952	Height	2.00E-08	Affymetrix [402,951]	1p34.2	SCMH1	rs6686842
18391952	Height	7.00E-09	Affymetrix [402,951]	13q14.3	DLEU7	rs3116602
18391952	Height	5.00E-09	Affymetrix [402,951]	1q42.13	ZNF678	rs1390401
18391952	Height	2.00E-09	Affymetrix [402,951]	4q31.22	HHIP	rs6854783
18391952	Height	6.00E-10	Affymetrix [402,951]	12q22	SOCS2	rs11107116
18391952	Height	4.00E-11	Affymetrix [402,951]	1p12	SPAG17	rs12735613
18391952	Height	3.00E-07	Affymetrix [402,951]	18q21.1	DYM	rs8099594
18391952	Height	8.00E-08	Affymetrix [402,951]	15q26.1	ACAN	rs8041863
18391952	Height	4.00E-12	Affymetrix [402,951]	6p21.31	C6orf106	rs2814993
18391952	Height	2.00E-13	Affymetrix [402,951]	4p15.32	LCORL	rs16896068
18391952	Height	2.00E-17	Affymetrix [402,951]	20q11.22	GDF5	rs6060373
18391952	Height	5.00E-13	Affymetrix [402,951]	6q22.32	LOC387103	rs4549631
18391952	Height	2.00E-12	Affymetrix [402,951]	2p16.1	EFEMP1	rs3791675
18391952	Height	8.00E-23	Affymetrix [402,951]	7q21.2	CDK6	rs2282978
18391952	Height	3.00E-18	Affymetrix [402,951]	12q14.3	HMGA2	rs1042725
18369459	Psoriasis	2E-06	Illumina [305,983]	13q13	COG6	rs7993214
18369459	Psoriasis	2.00E-26	Illumina [305,983]	6p21.33	HLA-C	rs2395029
18369459	Psoriasis	2.00E-39	Illumina [305,983]	6p21.33	HLA-C	rs10484554
18385676	Lung cancer	3.00E-18	Illumina [317,498]	15q25.1	CHRNA3, CHRNA5, PSMA4, LOC123688	rs8034191
18385676	Lung cancer	7E-06	Illumina [317,498]	1q23.2	CRP	rs2808630
18385676	Lung cancer	8E-06	Illumina [317,498]	3q28	IL1RAP	rs7626795
18385738	Lung cancer	5.00E-20	Illumina [310,023]	15q25.1	CHRNA3,CHRNA5, CHRNB4, PSMA4, LOC123688	rs8034191
18385739	Nicotine dependence	6.00E-20	Illumina [306,207]	15q25.1	CHRNA3,CHRNA5,CHRNB4	rs1051730
18372901	Colorectal cancer	9.00E-26	Illumina [541,628]	8q24.21	POU5FIP1, HsG57825, DQ515897	rs7014346
18372901	Colorectal cancer	8.00E-28	Illumina [541,628]	18q21.1	SMAD7	rs4939827
18372901	Colorectal cancer	6.00E-10	Illumina [541,628]	11q23.1	Intergenic	rs3802842
18372905	Colorectal cancer	3.00E-13	Illumina [547,647]	10p14	Intergenic	rs10795668
18372905	Colorectal cancer	3.00E-18	Illumina [547,647]	8q23.3	EIF3H	rs16892766
18372905	Colorectal cancer	5.00E-07	Illumina [547,647]	15q13.3	Intergenic	rs4779584
18372905	Colorectal cancer	2E-06	Illumina [547,647]	18q21.1	SMAD7	rs4939827
18372905	Colorectal cancer	7.00E-11	Illumina [547,647]	8q24.21	Intergenic	rs6983267
18372903	Type 2 diabetes	5.00E-14	Affymetrix and Illumina [2,202,892] (imputed)	7p15.1	JAZF1	rs864745
18372903	Type 2 diabetes	1.00E-08	Affymetrix and Illumina [2,202,892] (imputed)	3p14.1	ADAMTS9	rs4607103
18372903	Type 2 diabetes	2.00E-07	Affymetrix and Illumina [2,202,892] (imputed)	12q13.2	DCD	rs1153188
18372903	Type 2 diabetes	2.00E-07	Affymetrix and Illumina [2,202,892] (imputed)	3p25.2	SYN2, PPARG	rs17036101
18372903	Type 2 diabetes	1.00E-11	Affymetrix and Illumina [2,202,892] (imputed)	6p22.3	CDKAL1	rs6931514
18372903	Type 2 diabetes	7.00E-08	Affymetrix and Illumina [2,202,892] (imputed)	10q23.33	HHEX	rs5015480
18372903	Type 2 diabetes	7E-06	Affymetrix and Illumina [2,202,892] (imputed)	16q12.2	FTO	rs8050136
18372903	Type 2 diabetes	3.00E-23	Affymetrix and Illumina [2,202,892] (imputed)	10q25.2	TCF7L2	rs7903146
18372903	Type 2 diabetes	4.00E-07	Affymetrix and Illumina [2,202,892] (imputed)	11p15.1	KCNJ11	rs5215
18372903	Type 2 diabetes	2.00E-07	Affymetrix and Illumina [2,202,892] (imputed)	9p21.3	CDKN2A,CDKN2B	rs7020996
18372903	Type 2 diabetes	8.00E-08	Affymetrix and Illumina [2,202,892] (imputed)	3q27.2	IGF2BP2	rs4402960
18372903	Type 2 diabetes	4E-06	Affymetrix and Illumina [2,202,892] (imputed)	6p21.1	VEGFA	rs9472138
18372903	Type 2 diabetes	4.00E-08	Affymetrix and Illumina [2,202,892] (imputed)	1p12	NOTCH2, ADAM30	rs10923931
18372903	Type 2 diabetes	1.00E-09	Affymetrix and Illumina [2,202,892] (imputed)	2p21	THADA	rs7578597
18372903	Type 2 diabetes	1.00E-10	Affymetrix and Illumina [2,202,892] (imputed)	10p13	CDC123,CAMK1D	rs12779790
18372903	Type 2 diabetes	1.00E-09	Affymetrix and Illumina [2,202,892] (imputed)	12q21.1	TSPAN8,LGR5	rs7961581
18360741	Environmental confusion in the home	NS	Affymetrix [117,062] (pooled)	NR	NR
18364390	Psoriasis	1.00E-09	Illumina [~408,000] (pooled)	6p21.33	HLA-C	rs3134792
18364390	Psoriasis	1.00E-08	Illumina [~408,000] (pooled)	20q13.13	SPATA2	rs495337
18347602	Schizophrenia	2E-06	Affymetrix [492,900]	15q25.3	AGBL1	rs16977195
18347602	Schizophrenia	7E-06	Affymetrix [492,900]	Xq28	Intergenic	rs2159767
18347602	Schizophrenia	4E-06	Affymetrix [492,900]	1p36.22	Intergenic	rs4846033
18347602	Schizophrenia	0.000005	Affymetrix [492,900]	13q12.2	Intergenic	rs9512730
18347602	Schizophrenia	0.000006	Affymetrix [492,900]	16p12.2	ACSM1, BUCS1	rs151222
18347602	Schizophrenia	2E-06	Affymetrix [492,900]	1q31.1	Intergenic	rs10911902
18326623	Breast cancer	3.00E-08	Affymetrix [150,080]	6q22.33	ECHDC1,RNF146	rs2180341
18332876	Schizophrenia	1.00E-06	Illumina [~550,000] (pooled)	12q24.23	CCDC60	rs11064768
18327256	Serum urate	3.00E-70	Affymetrix [335,152]	4p16.1	SLC2A9	rs7442295
18327257	Serum urate	3.00E-09	Illumina [308,140]	4p16.1	SLC2A9	rs737267
18325910	Obesity	NS	Affymetrix [379,319]	NR	NR
18317468	Bipolar disorder	NS	Affymetrix [372,193]	NR	NR
18311140	Celiac disease	3.00E-11	Illumina [310,605]	1q31.2	RGS1	rs2816316
18311140	Celiac disease	7.00E-08	Illumina [310,605]	6q25.3	TAGAP	rs1738074
18311140	Celiac disease	4.00E-09	Illumina [310,605]	2q12.1	IL1RL1,IL18R1,IL18RAP, SLC9A4	rs13015714
18311140	Celiac disease	5.00E-09	Illumina [310,605]	3q28	LPP	rs1464510
18311140	Celiac disease	1.00E-09	Illumina [310,605]	3q25.33	IL12A, SCHIP1	rs17810546
18311140	Celiac disease	3.00E-13	Illumina [310,605]	4q27	KIAA1109, ADAD1, IL2, IL21	rs6822844
18311140	Celiac disease	8.00E-08	Illumina [310,605]	12q24.12	SH2B3, ATXN2	rs653178
18311140	Celiac disease	3.00E-07	Illumina [310,605]	3p21.31	CCR1, CCR3	rs6441961
18316681	Methamphetamine dependence	NS	Affymetrix [up to 466,883] (pooled)	NR	NR
18313986	Amyotrophic lateral sclerosis	Pending	Illumina [317,503]	Pending	Pending
18282107	Schizophrenia	9.00E-07	Affymetrix [510,552]	7q22.1	RELN	rs7341475
18264097	Prostate cancer	9.00E-29	Illumina [541,129]	10q11.23	MSMB	rs10993994
18264097	Prostate cancer	6.00E-10	Illumina [541,129]	6q25.3	SLC22A3	rs9364554
18264097	Prostate cancer	2.00E-09	Illumina [541,129]	Xp11.22	NUDT10, NUDT11	rs5945619
18264097	Prostate cancer	1.00E-07	Illumina [541,129]	8q24.21	Intergenic	rs1016343
18264097	Prostate cancer	1.00E-06	Illumina [541,129]	17q24.3	Intergenic	rs1859962
18264097	Prostate cancer	9.00E-12	Illumina [541,129]	17q12	HNF1B	rs7501939
18264097	Prostate cancer	3.00E-16	Illumina [541,129]	8q24.21	Intergenic	rs4242384
18264097	Prostate cancer	9.00E-13	Illumina [541,129]	8q24.21	Intergenic	rs6983267
18264097	Prostate cancer	3.00E-08	Illumina [541,129]	3p12.1	SLC22A3	rs2660753
18264097	Prostate cancer	1.00E-09	Illumina [541,129]	7q21.3	LMTK2	rs6465657
18264097	Prostate cancer	2.00E-18	Illumina [541,129]	19q13.33	KLK3	rs2735839
18264097	Prostate cancer	2.00E-12	Illumina [541,129]	11q13.2	Intergenic	rs7931342
18264098	Prostate cancer	4.00E-13	Illumina [310,520]	Xp11.22	NUDT10, NUDT11, LOC340602, GSPT2, MAGED1	rs5945572
18264098	Prostate cancer	8.00E-09	Illumina [310,520]	2p15	EHBP1	rs721048
18264096	Prostate cancer	7.00E-13	Illumina [527,869]	10q11.23	MSMB	rs10993994
18264096	Prostate cancer	1.00E-09	Illumina [527,869]	17q12	HNF1B	rs4430796
18264096	Prostate cancer	3.00E-19	Illumina [527,869]	8q24.21	Intergenic	rs4242382
18264096	Prostate cancer	7.00E-12	Illumina [527,869]	8q24.21	Intergenic	rs6983267
18264096	Prostate cancer	2E-06	Illumina [527,869]	7p15.2	JAZF1	rs10486567
18264096	Prostate cancer	2.00E-09	Illumina [527,869]	11q13.2	Intergenic	rs10896449
18264096	Prostate cancer	2.00E-07	Illumina [527,869]	10q26.13	CTBP2	rs4962416
18262040	LDL cholesterol	1.00E-33	Affymetrix and Illumina [up to 461,986]	1p13.3	CELSR2,PSRC1	rs599839
18262040	LDL cholesterol	1.00E-20	Affymetrix and Illumina [up to 461,986]	19q13.32	APOC1	rs4420638
18262040	LDL cholesterol	1.00E-09	Affymetrix and Illumina [up to 461,986]	2p24.1	APOB	rs562338
18245381	Fetal hemoglobin levels	1.00E-21	Affymetrix [362,129]	11p15.4	HBB	rs4910742
18245381	Fetal hemoglobin levels	7.00E-35	Affymetrix [362,129]	2p15	BCL11A	rs1186868
18239089	Recombination rate (females)	2.00E-12	Illumina [309,241]	4p16.3	RNF212,SPON2	rs1670533
18239089	Recombination rate (males)	3.00E-24	Illumina [309,241]	4p16.3	RNF212,SPON2	rs3796619
18227835	Nicotine dependence	NS	Affymetrix [460,959]	NR	NR
18252221	Iris color	1.00E-43	Affymetrix and Illumina [up to ~500,000] (pooled)	15q13.1	HERC2	rs916977
18067574	General cognitive ability	NS	Affymetrix [449,127]	NR	NR
18204446	Systemic lupus erythematosus in women	2.00E-23	Illumina [317,501]	16p11.2	ITGAM	rs9888739
18204446	Systemic lupus erythematosus in women	1.00E-07	Illumina [317,501]	1q25.1	Intergenic	rs10798269
18204446	Systemic lupus erythematosus in women	3.00E-10	Illumina [317,501]	11p15.5	KIAA1542	rs4963128
18204446	Systemic lupus erythematosus in women	2.00E-52	Illumina [317,501]	6p21.33	HLA region	rs3131379
18204446	Systemic lupus erythematosus in women	4.00E-19	Illumina [317,501]	7q32.1	IRF5, TNPO3	rs12537284
18204446	Systemic lupus erythematosus in women	7.00E-09	Illumina [317,501]	3p14.3	PXK	rs6445975
18204098	Systemic lupus erythematosus	1.00E-10	Illumina [502,033]	8p23.1	C8orf13, BLK	rs13277113
18204098	Systemic lupus erythematosus	9.00E-14	Illumina [502,033]	2q32.3	STAT4	rs7574865
18204098	Systemic lupus erythematosus	4E-06	Illumina [502,033]	5p12	GHR	rs979233
18204098	Systemic lupus erythematosus	0.000006	Illumina [502,033]	18q22.3	SOCS6	rs17083844
18204098	Systemic lupus erythematosus	7E-06	Illumina [502,033]	1p31.3	NEGR1	rs12141391
18204098	Systemic lupus erythematosus	2.00E-11	Illumina [502,033]	7q32.1	IRF5, TNPO3	rs10488631
18204098	Systemic lupus erythematosus	3.00E-21	Illumina [502,033]	6p21.32	HLA-DQA1	rs2187668
18204098	Systemic lupus erythematosus	0.000003	Illumina [502,033]	9q34.13	NTNG2	rs11243676
18204098	Systemic lupus erythematosus	3.00E-11	Illumina [502,033]	16p11.2	ITGAM, ITGAX	rs11574637
18204447	Systemic lupus erythematosus	4.00E-10	Affymetrix [85,042]	4q24	BANK1	rs10516487
18198356	Type 1 diabetes	9.00E-10	Illumina [543,071]	12q13.2	RAB5B, SUOX, IKZF4, ERBB3, CDK2	rs1701704
18195134	Response to interferon beta therapy	NS	Affymetrix [~100,000] (pooled)	NR	NR
18193044	HDL cholesterol	2.00E-13	Affymetrix [389,878]	1q42.13	GALNT2	rs4846914
18193044	HDL cholesterol	3.00E-10	Affymetrix [389,878]	9q31.1	ABCA1	rs3890182
18193044	HDL cholesterol	2.00E-32	Affymetrix [389,878]	15q22.1	LIPC	rs1800588
18193044	HDL cholesterol	9.00E-23	Affymetrix [389,878]	8p21.3	LPL	rs328
18193044	HDL cholesterol	2.00E-07	Affymetrix [389,878]	18q21.1	LIPG, ACAA2	rs2156552
18193044	HDL cholesterol	1.00E-73	Affymetrix [389,878]	16q13	CETP	rs1800775
18193044	LDL cholesterol	3.00E-29	Affymetrix [389,878]	1p13.3	CELSR2,PSRC1,SORT1	rs646776
18193044	LDL cholesterol	3.00E-08	Affymetrix [389,878]	19p13.11	CILP2, PBX4	rs16996148
18193044	LDL cholesterol	1.00E-60	Affymetrix [389,878]	19q13.32	APOE, APOC1, APOC4, APOC2	rs4420638
18193044	LDL cholesterol	2.00E-51	Affymetrix [389,878]	19p13.2	LDLR	rs6511720
18193044	LDL cholesterol	2.00E-44	Affymetrix [389,878]	1p32.3	PCSK9	rs11591147
18193044	LDL cholesterol	1.00E-20	Affymetrix [389,878]	5q13.3	HMGCR	rs12654264
18193044	LDL cholesterol	1.00E-21	Affymetrix [389,878]	2p24.1	APOB	rs693
18193044	Triglycerides	7.00E-22	Affymetrix [389,878]	7q11.23	BCL7B, TBL2, MLXIPL	rs17145738
18193044	Triglycerides	7.00E-15	Affymetrix [389,878]	1q42.13	GALNT2	rs4846914
18193044	Triglycerides	4.00E-09	Affymetrix [389,878]	19p13.11	CILP2, PBX4	rs16996148
18193044	Triglycerides	2.00E-08	Affymetrix [389,878]	1p31.3	ANGPTL3, DOCK7, ATG4C	rs12130333
18193044	Triglycerides	2.00E-28	Affymetrix [389,878]	8p21.3	LPL	rs328
18193044	Triglycerides	3.00E-14	Affymetrix [389,878]	2p23.3	GCKR	rs780094
18193044	Triglycerides	2.00E-07	Affymetrix [389,878]	2p24.1	APOB	rs693
18193044	Triglycerides	2.00E-17	Affymetrix [389,878]	11q23.3	APOA1, APOC3, APOA4, APOA5, ZNF259, BUD13	rs28927680
18193044	Triglycerides	4.00E-17	Affymetrix [389,878]	8q24.13	TRIB1	rs17321515
18193046	Triglycerides	1.00E-10	Perlegen [up to 216,774]	7q11.23	MLXIPL	rs3812316
18193046	Triglycerides	5.00E-08	Perlegen [up to 216,774]	11q23.3	APOA1,KIAA0999,LOC645044	rs2075292
18193046	Triglycerides	5.00E-12	Perlegen [up to 216,774]	8p21.3	LPL, C8orf35, SLC18A1	rs326
18193046	Triglycerides	2.00E-26	Perlegen [up to 216,774]	11q23.3	LOC440069, MGC13125	rs1558861
18193045	Height	2.00E-16	Illumina and Affymetrix [~2,261,000] (imputed)	20q11.22	BFZB	rs6060369
18193045	Height	0.000003	Illumina and Affymetrix [~2,261,000] (imputed)	5q14.1	HOMER1	rs10078095
18193045	Height	1.00E-06	Illumina and Affymetrix [~2,261,000] (imputed)	3q23	ZBTB38	rs724016
18193045	Height	4.00E-07	Illumina and Affymetrix [~2,261,000] (imputed)	4q12	PDGFRA	rs17690232
18193045	Height	8.00E-07	Illumina and Affymetrix [~2,261,000] (imputed)	15q26.1	POLG	rs4932217
18193043	HDL cholesterol	3.00E-08	Illumina and Affymetrix [~2,261,000] (imputed)	12q24.11	MVK,MMAB	rs2338104
18193043	HDL cholesterol	1.00E-07	Illumina and Affymetrix [~2,261,000] (imputed)	16q22.1	LCAT	rs255052
18193043	HDL cholesterol	1.00E-10	Illumina and Affymetrix [~2,261,000] (imputed)	9q31.1	ABCA1	rs4149268
18193043	HDL cholesterol	3.00E-14	Illumina and Affymetrix [~2,261,000] (imputed)	1q42.13	GALNT2	rs2144300
18193043	HDL cholesterol	4.00E-19	Illumina and Affymetrix [~2,261,000] (imputed)	8p21.3	LPL	rs10503669
18193043	HDL cholesterol	3.00E-20	Illumina and Affymetrix [~2,261,000] (imputed)	15q22.1	LIPC	rs4775041
18193043	HDL cholesterol	3.00E-31	Illumina and Affymetrix [~2,261,000] (imputed)	16q13	CETP	rs9989419
18193043	HDL cholesterol	7.00E-39	Illumina and Affymetrix [~2,261,000] (imputed)	16q13	CETP	rs1864163
18193043	HDL cholesterol	2.00E-57	Illumina and Affymetrix [~2,261,000] (imputed)	16q13	CETP	rs3764261
18193043	HDL cholesterol	6.00E-12	Illumina and Affymetrix [~2,261,000] (imputed)	18q21.1	LIPG	rs2156552
18193043	LDL cholesterol	6.00E-33	Illumina and Affymetrix [~2,261,000] (imputed)	1p13.3	CELSR2,PSRC1,SORT1	rs599839
18193043	LDL cholesterol	5.00E-08	Illumina and Affymetrix [~2,261,000] (imputed)	6p21.32	B3GALT4	rs2254287
18193043	LDL cholesterol	3.00E-43	Illumina and Affymetrix [~2,261,000] (imputed)	19q13.32	APOE,APOC1,APOC4	rs4420638
18193043	LDL cholesterol	4.00E-11	Illumina and Affymetrix [~2,261,000] (imputed)	1p32.3	PCSK9	rs11206510
18193043	LDL cholesterol	4.00E-26	Illumina and Affymetrix [~2,261,000] (imputed)	19p13.2	LDLR	rs6511720
18193043	LDL cholesterol	6.00E-22	Illumina and Affymetrix [~2,261,000] (imputed)	2p24.1	APOB	rs562338
18193043	LDL cholesterol	3.00E-09	Illumina and Affymetrix [~2,261,000] (imputed)	19p13.11	NCAN,CILP2	rs16996148
18193043	Triglycerides	6.00E-32	Illumina and Affymetrix [~2,261,000]] (imputed)	2p23.3	GCKR	rs780094
18193043	Triglycerides	8.00E-07	Illumina and Affymetrix [~2,261,000]] (imputed)	1q42.13	GALNT2	rs2144300
18193043	Triglycerides	3.00E-09	Illumina and Affymetrix [~2,261,000]] (imputed)	19p13.3	NCAN,CILP2	rs16996148
18193043	Triglycerides	2.00E-10	Illumina and Affymetrix [~2,261,000]] (imputed)	1p31.3	ANGPTL3	rs1748195
18193043	Triglycerides	2.00E-08	Illumina and Affymetrix [~2,261,000]] (imputed)	15q22.1	LIPC	rs4775041
18193043	Triglycerides	4.00E-22	Illumina and Affymetrix [~2,261,000]] (imputed)	8p21.3	LPL	rs10503669
18193043	Triglycerides	1.00E-26	Illumina and Affymetrix [~2,261,000]] (imputed)	11q23.3	APOA5, APOA4, APOC3, APOA1	rs12286037
18193043	Triglycerides	7.00E-13	Illumina and Affymetrix [~2,261,000]] (imputed)	8q24.13	TRIB1	rs17321515
18193043	Triglycerides	2.00E-12	Illumina and Affymetrix [~2,261,000]] (imputed)	7q11.23	MLXIPL	rs17145738
18179892	LDL cholesterol	1.00E-07	Affymetrix [400,496]	1p13.3	CELSR2,PSRC1	rs599839
18179892	LDL cholesterol	5.00E-07	Affymetrix [400,496]	2p23.3	GCKR	rs780094
18179892	LDL cholesterol	3.00E-11	Affymetrix [400,496]	11q23.3	APOA1,APOC3,APOA5	rs6589566
18179892	Serum urate	2.00E-15	Affymetrix [400,496]	4p16.1	SLC2A9,WDR1	rs7442295
18159244	Early onset extreme obesity	1.00E-07	Affymetrix [440,794]	16q12.2	FTO	rs1121980
18073375	Prostate cancer	NS	Illumina & Affymetrix [60,275]	NR	NR
18084291	Amyotrophic lateral sclerosis	5.00E-08	Illumina [311,946]	7q36.2	DPP6	rs10260404
18084291	Amyotrophic lateral sclerosis	0.000009	Illumina [311,946]	15q22.1	LIPC	rs3825776
18084291	Amyotrophic lateral sclerosis	0.000009	Illumina [311,946]	2p24.2	Intergenic	rs7580332
18057069	Amyotrophic lateral sclerosis	0.000003	Illumina [497,917]	7q36.2	DPP6	rs10260404
18075462	Coronary spasm in women	9.00E-07	Affymetrix [97,552]	14q21.1	Intergenic	rs10498345
17998437	Alzheimer's disease	2.00E-44	Affymetrix [469,438]	19q13.32	APOE, APOC	rs4420638
17997608	Serum urate	2.00E-16	Affymetrix [362,129]	4p16.1	GLUT9	rs6855911
17982456	Rheumatoid arthritis	1.00E-09	Affymetrix [79,853]	6q23.3	TNFAIP3, OLIG3	rs10499194
17982456	Rheumatoid arthritis	1.00E-07	Affymetrix [79,853]	6q23.3	TNFAIP3, OLIG3	rs6920220
17975299	Alzheimer's disease	1.00E-39	Affymetrix [~502,627]	19q13.32	APOE	rs4420638
17952075	Blond vs. brown hair	4.00E-30	Illumina [317,511]	12q21.33	KITLG	rs12821256
17952075	Blond vs. brown hair	2.00E-13	Illumina [317,511]	16q24.3	MC1R	rs1805007
17952075	Blond vs. brown hair	6.00E-35	Illumina [317,511]	15q13.1	OCA2	rs1667394
17952075	Blond vs. brown hair	1.00E-48	Illumina [317,511]	14q32.12	SLC24A4	rs12896399
17952075	Blue vs brown eyes	0	Illumina [317,511]	15q13.1	OCA2	rs1667394
17952075	Blue vs. green eyes	4.00E-38	Illumina [317,511]	14q32.12	SLC24A4	rs12896399
17952075	Blue vs. green eyes	2.00E-53	Illumina [317,511]	15q13.1	OCA2	rs1667394
17952075	Blue vs. green eyes	3.00E-12	Illumina [317,511]	11q14.3	TYR	rs1393350
17952075	Freckles	4.00E-18	Illumina [317,511]	6p25.3	SEC5L1,IRF4	rs1540771
17952075	Freckles	2.00E-11	Illumina [317,511]	11q14.3	TYR	rs1042602
17952075	Freckles	1.00E-96	Illumina [317,511]	16q24.3	MC1R	rs1805007
17952075	Red vs non-red hair	0	Illumina [317,511]	16q24.3	MC1R	rs1805007
17952075	Skin sensitivity to sun	2E-06	Illumina [317,511]	11q14.3	TYR	rs1393350
17952075	Skin sensitivity to sun	2.00E-55	Illumina [317,511]	16q24.3	MC1R	rs1805007
17999355	Skin pigmentation by reflectance spectroscopy	1.00E-50	Perlegen [1,502,205] (pooled)	15q21.1	SLC24A5	rs1834640
17999355	Skin pigmentation by reflectance spectroscopy	4.00E-10	Perlegen [1,502,205] (pooled)	11q14.3	TYR	rs1042602
17999355	Skin pigmentation by reflectance spectroscopy	3.00E-11	Perlegen [1,502,205] (pooled)	5p13.3	SLC45A2	rs16891982
17934461	Colorectal cancer	1.00E-12	Illumina [547,647]	18q21.1	SMAD7	rs4939827
17911428	Lupus	NS	Affymetrix [241,701]	NR	NR
17903293	Select biomarker traits	1.00E-14	Affymetrix [70,897]	1q23.2	FCER1A,OR10J3	rs2494250
17903293	Select biomarker traits	3.00E-08	Affymetrix [70,897]	1q23.2	CRP	rs2794520
17903293	Select biomarker traits	5.00E-07	Affymetrix [70,897]	1p31.1	Intergenic	rs7552393
17903293	Select biomarker traits	2E-06	Affymetrix [70,897]	10q21.1	Intergenic	rs583012
17903293	Select biomarker traits	2E-06	Affymetrix [70,897]	6q21	Intergenic	rs1417352
17903293	Select biomarker traits	1.00E-06	Affymetrix [70,897]	6q15	Intergenic	rs10485165
17903293	Select biomarker traits	1.00E-06	Affymetrix [70,897]	5q23.2	Intergenic	rs1119582
17903293	Select biomarker traits	1.00E-06	Affymetrix [70,897]	10q26.2	PTPRE, MKI67	rs2387326
17903293	Select biomarker traits	1.00E-06	Affymetrix [70,897]	15q21.3	Intergenic	rs10518765
17903293	Select biomarker traits	1.00E-06	Affymetrix [70,897]	1q23.2	IGSF4B	rs10489849
17903293	Select biomarker traits	1.00E-06	Affymetrix [70,897]	9q21.32	Intergenic	rs1998303
17903293	Select biomarker traits	1.00E-06	Affymetrix [70,897]	4q31.1	CLGN, ELMOD2	rs17532515
17903293	Select biomarker traits	4E-06	Affymetrix [70,897]	14q23.2	Intergenic	rs8005745
17903293	Select biomarker traits	0.000003	Affymetrix [70,897]	7p21.3	Intergenic	rs7778619
17903293	Select biomarker traits	0.000003	Affymetrix [70,897]	1q23.2	IGSF4B	rs1474747
17903293	Select biomarker traits	0.000003	Affymetrix [70,897]	11q23.2	DRD2	rs1079596
17903293	Select biomarker traits	0.000003	Affymetrix [70,897]	13q21.1	Intergenic	rs10507577
17903293	Select biomarker traits	2E-06	Affymetrix [70,897]	13q14.11	Intergenic	rs10492681
17903293	Select biomarker traits	2E-06	Affymetrix [70,897]	7p13	Intergenic	rs1486139
17903293	Select biomarker traits	8.00E-07	Affymetrix [70,897]	19q12	ZNF536	rs746961
17903293	Select biomarker traits	4.00E-12	Affymetrix [70,897]	1q23.2	OR10J1	rs4128725
17903300	Body mass index	1.00E-07	Affymetrix [70,897]	7q32.3	Intergenic	rs1106683
17903300	Body mass index	2E-06	Affymetrix [70,897]	7q23.3	Intergenic	rs1106684
17903300	Body mass index	8E-06	Affymetrix [70,897]	13q21.32	Intergenic	rs1333026
17903300	Waist circumference traits	2.00E-07	Affymetrix [70,897]	8q21.1	GDAP1	rs4471028
17903300	Waist circumference traits	2E-06	Affymetrix [70,897]	3q13.31	Intergenic	rs1875517
17903308	Sleep duration	1.00E-07	Affymetrix [70,897]	3p22.1	MYR1P	rs6599077
17903308	Sleep duration	4E-06	Affymetrix [70,897]	13q21.2	Intergenic	rs10492604
17903308	Sleepiness	3.00E-08	Affymetrix [70,897]	5q11.2	PDE4D	rs1823068
17903308	Sleepiness	0.000003	Affymetrix [70,897]	8q13.3	EYA1	rs2218488
17903292	Cystatin C	9.00E-09	Affymetrix [70,897]	20p11.21	CST9L, CST9, CST3	rs1158167
17903292	Thyroid stimulating hormone	4E-06	Affymetrix [70,897]	7p15.3	Intergenic	rs6977660
17903292	Thyroid stimulating hormone	8E-06	Affymetrix [70,897]	7p15.3	RAPGEF5	rs10499559
17903292	Thyroid stimulating hormone	7E-06	Affymetrix [70,897]	6q21	HACE1	rs9322817
17903292	Urinary albumin excretion	2E-06	Affymetrix [70,897]	11q23.2	FAM55B	rs1712790
17903292	Urinary albumin excretion	8E-06	Affymetrix [70,897]	21q21.3	Intergenic	rs9305354
17903299	Blood lipid traits	NS	Affymetrix [70,897]	NR	NR
17903296	Bone mineral density	2.00E-07	Affymetrix [70,897]	13q21.31	Intergenic	rs9317284
17903296	Bone mineral density	1.00E-06	Affymetrix [70,897]	10p15.2	Intergenic	rs2165468
17903296	Bone mineral density	1.00E-06	Affymetrix [70,897]	20q11.23	CTNNBL1	rs4811196
17903296	Bone mineral density	0.000003	Affymetrix [70,897]	3p24.1	RBMS3	rs10510628
17903296	Bone mineral density	3.00E-07	Affymetrix [70,897]	16q23.3	Intergenic	rs4087296
17903296	Bone mineral density	1.00E-06	Affymetrix [70,897]	12q21.1	Intergenic	rs10506701
17903296	Bone mineral density	0.000003	Affymetrix [70,897]	7q35	CNTNAP2	rs2214681
17903296	Bone mineral density	2E-06	Affymetrix [70,897]	4p16.1	Intergenic	rs9291683
17903296	Hip geometry	2.00E-07	Affymetrix [70,897]	5q14.3	GPR98	rs10514345
17903296	Hip geometry	2.00E-07	Affymetrix [70,897]	5p14.1	Intergenic	rs2548003
17903296	Hip geometry	2.00E-07	Affymetrix [70,897]	12q21.31	Intergenic	rs10506821
17903296	Hip geometry	0.000003	Affymetrix [70,897]	6p24.1	PHACTR1	rs4715166
17903296	Hip geometry	6.00E-07	Affymetrix [70,897]	1p11.2	Intergenic	rs6600671
17903296	Hip geometry	4E-06	Affymetrix [70,897]	11q23.2	Intergenic	rs638882
17903296	Hip geometry	2E-06	Affymetrix [70,897]	18q12.1	Intergenic	rs4131805
17903296	Hip geometry	0.000003	Affymetrix [70,897]	12p13.31	VAMP1	rs10492096
17903296	Hip geometry	7.00E-07	Affymetrix [70,897]	11q14.1	Intergenic	rs1452928
17903296	Hip geometry	2E-06	Affymetrix [70,897]	3p14.1	Intergenic	rs922948
17903296	Hip geometry	5.00E-07	Affymetrix [70,897]	3q12.3	Intergenic	rs991258
17903296	Hip geometry	0.000003	Affymetrix [70,897]	13q13.3	Intergenic	rs1590305
17903296	Hip geometry	6.00E-07	Affymetrix [70,897]	5q13.2	ZNF366	rs10515148
17903296	Hip geometry	4E-06	Affymetrix [70,897]	3p24.3	KCNH8	rs2053506
17903296	Hip geometry	6.00E-07	Affymetrix [70,897]	3p14.3	ERC2	rs2054989
17903296	Hip geometry	2.00E-07	Affymetrix [70,897]	8p12	NRG1	rs10503887
17903304	Atrial fibrillation	0.000005	Affymetrix [70,897]	13q14	Intergenic	rs958546
17903304	Atrial fibrillation	0.000009	Affymetrix [70,897]	11q22.1	CNTN5	rs10501920
17903304	Atrial fibrillation	8E-06	Affymetrix [70,897]	15q23	KIAA1598	rs4776472
17903304	Heart failure	0.000009	Affymetrix [70,897]	10q25.3	KIAA1598	rs740363
17903304	Major CVD	7E-06	Affymetrix [70,897]	6p24.1	Intergenic	rs499818
17903302	Blood pressure	2E-06	Affymetrix [70,897]	1p31.3	Intergenic	rs10493340
17903302	Blood pressure	0.000003	Affymetrix [70,897]	8q13.3	Intergenic	rs1963982
17903302	Blood pressure	4E-06	Affymetrix [70,897]	5q22.1	CAMK4	rs10491334
17903302	Blood pressure	7E-06	Affymetrix [70,897]	6q15	Intergenic	rs2509458
17903302	Blood pressure	1.00E-09	Affymetrix [70,897]	16q23.3	CDH13	rs3096277
17903302	Blood pressure	3.00E-07	Affymetrix [70,897]	2q36.3	CCL20, WDR69	rs7591163
17903302	Blood pressure	0.000005	Affymetrix [70,897]	14q24.3	C14orf118	rs2121070
17903302	Blood pressure	4E-06	Affymetrix [70,897]	3p26.3	CNTN4	rs4370013
17903302	Blood pressure	0.000003	Affymetrix [70,897]	14q24.3	Intergenic	rs935334
17903302	Tonometry	2E-06	Affymetrix [70,897]	20q13.13	PREX1	rs6063312
17903302	Tonometry	2E-06	Affymetrix [70,897]	13q13.3	GPC6	rs6492654
17903302	Tonometry	4E-06	Affymetrix [70,897]	17p12	HS3ST3A1	rs10521232
17903302	Tonometry	8E-06	Affymetrix [70,897]	7q33	EXOC4	rs10488172
17903302	Tonometry	4E-06	Affymetrix [70,897]	3q24	SLC9A9	rs1371924
17903302	Tonometry	4E-06	Affymetrix [70,897]	1q25.1	TNR	rs3766680
17903302	Tonometry	0.000003	Affymetrix [70,897]	2q14.3	CNTNAP5	rs1367248
17903302	Tonometry	2E-06	Affymetrix [70,897]	8p22	VPS37A	rs3793427
17903302	Tonometry	0.000006	Affymetrix [70,897]	3p22.3	Intergenic	rs10514688
17903302	Tonometry	0.000006	Affymetrix [70,897]	9q31.2	Intergenic	rs7042864
17903302	Tonometry	2.00E-07	Affymetrix [70,897]	3p24.1	TGFBR2	rs3773643
17903302	Tonometry	8E-06	Affymetrix [70,897]	6q25.2	SYNE1	rs1322512
17903302	Tonometry	0.000003	Affymetrix [70,897]	5q14.3	MEF2C	rs770189
17903295	Aging traits	1.00E-08	Affymetrix [70,897]	2p12	Intergenic	rs10496265
17903295	Aging traits	8E-06	Affymetrix [70,897]	3q25.31	KCNAB1	rs3772255
17903295	Aging traits	7E-06	Affymetrix [70,897]	15q25.3	KLHL25	rs7176093
17903295	Aging traits	6.00E-07	Affymetrix [70,897]	12q24.23	CCDC60	rs7137869
17903295	Aging traits	0.000006	Affymetrix [70,897]	1q42.3	GNG4	rs291353
17903295	Aging traits	2E-06	Affymetrix [70,897]	2q24.1	GALNT13	rs958672
17903295	Aging traits	3.00E-07	Affymetrix [70,897]	2p12	Intergenic	rs10496262
17903295	Aging traits	0.000003	Affymetrix [70,897]	7q21.11	Intergenic	rs2371208
17903295	Aging traits	7.00E-08	Affymetrix [70,897]	12p11.22	Intergenic	rs1463605
17903295	Aging traits	8.00E-08	Affymetrix [70,897]	11q14.3	Intergenic	rs1528753
17903295	Morbidity-free survival	2.00E-09	Affymetrix [70,897]	1q24.2	DPT	rs1412337
17903295	Morbidity-free survival	2.00E-09	Affymetrix [70,897]	5p15.32	Intergenic	rs32566
17903295	Morbidity-free survival	8.00E-08	Affymetrix [70,897]	6p24.3	Intergenic	rs10484246
17903295	Morbidity-free survival	9.00E-07	Affymetrix [70,897]	16q21	Intergenic	rs2639889
17903295	Morbidity-free survival	5.00E-07	Affymetrix [70,897]	8p22	Intergenic	rs4831837
17903298	Diabetes related insulin traits	2E-06	Affymetrix [70,897]	14q12	Intergenic	rs2877832
17903298	Diabetes related insulin traits	0.000009	Affymetrix [70,897]	13q21.33	Intergenic	rs2066219
17903298	Diabetes related insulin traits	0.000003	Affymetrix [70,897]	14q12	Intergenic	rs2877832
17903298	Diabetes related insulin traits	8E-06	Affymetrix [70,897]	7p15.1	CPVL	rs10486607
17903298	Fasting plasma glucose	2.00E-08	Affymetrix [70,897]	8p11.21	ZMAT4	rs2722425
17903298	Fasting plasma glucose	0.000005	Affymetrix [70,897]	4q27	PRDM5	rs180730
17903298	Fasting plasma glucose	0.000006	Affymetrix [70,897]	4q27	PRDM5	rs180730
17903298	Fasting plasma glucose	0.000009	Affymetrix [70,897]	8p11.21	ZMAT4	rs2722425
17903298	Fasting plasma glucose	7E-06	Affymetrix [70,897]	5q23.3	Intergenic	rs7731657
17903298	Fasting plasma glucose	0.000005	Affymetrix [70,897]	3p24.1	Intergenic	rs10510634
17903298	Incident diabetes	7.00E-07	Affymetrix [70,897]	2q32.3	TMEFF2	rs10497721
17903305	Breast cancer	7.00E-07	Affymetrix [70,897]	12q21.1	Intergenic	rs1154865
17903305	Breast cancer	0.000006	Affymetrix [70,897]	15q21.1	FBN1	rs1876206
17903305	Breast cancer	0.000006	Affymetrix [70,897]	21q21.3	GRIK1	rs458685
17903305	Breast cancer	0.000005	Affymetrix [70,897]	2p16.1	Intergenic	rs10490113
17903305	Breast cancer	0.000003	Affymetrix [70,897]	7q11.22	Intergenic	rs10263639
17903305	Breast cancer	5.00E-07	Affymetrix [70,897]	5q34	Intergenic	rs6556756
17903305	Breast cancer	8.00E-08	Affymetrix [70,897]	17q21.33	COL1A1	rs2075555
17903305	Breast cancer	1.00E-06	Affymetrix [70,897]	18q21.2	Intergenic	rs1978503
17903305	Breast cancer	2E-06	Affymetrix [70,897]	13q32.1	ABCC4	rs1926657
17903305	Prostate cancer	2E-06	Affymetrix [70,897]	3p22.2	CTDSPL	rs9311171
17903305	Prostate cancer	2E-06	Affymetrix [70,897]	13q33.1	Intergenic	rs1529276
17903305	Prostate cancer	0.000003	Affymetrix [70,897]	6p12.2	PKHD1	rs10498792
17903305	Prostate cancer	0.000003	Affymetrix [70,897]	5q14.3	HAPLN1	rs4466137
17903305	Prostate cancer	0.000005	Affymetrix [70,897]	3q24	Intergenic	rs345013
17903306	Electrocardiographic traits	8E-06	Affymetrix [70,897]	13q12.2	RPL21	rs10507380
17903306	Electrocardiographic traits	3.00E-07	Affymetrix [70,897]	2q22.1	Intergenic	rs882300
17903306	Heart rate variability traits	7E-06	Affymetrix [70,897]	4q34	NEIL3	rs1395479
17903306	Heart rate variability traits	8E-06	Affymetrix [70,897]	13q13.3	DCAMKL1	rs9315385
17903303	Coronary artery calcification	1.00E-06	Affymetrix [70,897]	1p22.2	Intergenic	rs2390582
17903303	Coronary artery calcification	7E-06	Affymetrix [70,897]	12q23.2	DR1M	rs10507130
17903303	Coronary artery calcification	0.000006	Affymetrix [70,897]	14q24.2	NUMB	rs10483853
17903303	Other subclinical atherosclerosis traits	4.00E-07	Affymetrix [70,897]	2q33.2	ABI2	rs1376877
17903303	Other subclinical atherosclerosis traits	2E-06	Affymetrix [70,897]	10q11.22	LRRC18	rs3849150
17903303	Other subclinical atherosclerosis traits	0.000005	Affymetrix [70,897]	5p15.2	DNAH5	rs2896103
17903303	Other subclinical atherosclerosis traits	0.000009	Affymetrix [70,897]	5p15.2	DNAH5	rs1502050
17903303	Other subclinical atherosclerosis traits	0.000009	Affymetrix [70,897]	11q14.3	Intergenic	rs1350445
17903303	Other subclinical atherosclerosis traits	7E-06	Affymetrix [70,897]	4q28.1	Intergenic	rs1320267
17903303	Other subclinical atherosclerosis traits	0.000006	Affymetrix [70,897]	5p15.2	DNAH5	rs7715811
17903303	Other subclinical atherosclerosis traits	0.000006	Affymetrix [70,897]	1q31.1	Intergenic	rs1400544
17903297	Cognitive test performance	1.00E-06	Affymetrix [70,897]	1p22.2	Intergenic	rs2179965
17903297	Cognitive test performance	2E-06	Affymetrix [70,897]	4q13.2	Intergenic	rs1155865
17903297	Cognitive test performance	2E-06	Affymetrix [70,897]	6p23	Intergenic	rs6914079
17903297	Cognitive test performance	2E-06	Affymetrix [70,897]	21q21.3	Intergenic	rs2832077
17903297	Cognitive test performance	2E-06	Affymetrix [70,897]	14q24.3	Intergenic	rs2352904
17903297	Cognitive test performance	0.000003	Affymetrix [70,897]	5q32	Intergenic	rs9325032
17903297	Cognitive test performance	4E-06	Affymetrix [70,897]	11q14.1	Intergenic	rs530965
17903297	Cognitive test performance	0.000006	Affymetrix [70,897]	11q25	NCAPD3	rs1031381
17903297	Cognitive test performance	0.000009	Affymetrix [70,897]	2q22.1	Intergenic	rs934299
17903297	Cognitive test performance	8E-06	Affymetrix [70,897]	9q22.2	DIRAS2	rs1831521
17903297	Cognitive test performance	8E-06	Affymetrix [70,897]	12p11.1	Intergenic	rs9300212
17903297	Cognitive test performance	0.000006	Affymetrix [70,897]	1q42.2	TARBP1	rs10489896
17903297	Cognitive test performance	0.000005	Affymetrix [70,897]	17q22	PPM1E	rs9303401
17903297	Cognitive test performance	0.000003	Affymetrix [70,897]	12q23.3	POLR3B, RFX4	rs3891355
17903297	Volumetric brain MRI	4.00E-08	Affymetrix [70,897]	20q13.33	CDH4	rs1970546
17903297	Volumetric brain MRI	0.000003	Affymetrix [70,897]	11p13	EHF	rs5028798
17903297	Volumetric brain MRI	0.000006	Affymetrix [70,897]	11q22.1	CNTN5	rs952700
17903297	Volumetric brain MRI	0.000009	Affymetrix [70,897]	4q31.3	Intergenic	rs360929
17903297	Volumetric brain MRI	0.000003	Affymetrix [70,897]	11q23.2	NNMT	rs2847476
17903301	Echocardiographic traits	1.00E-07	Affymetrix [70,897]	4p15.31	SLIT2	rs1379659
17903301	Echocardiographic traits	7E-06	Affymetrix [70,897]	5q14.3	Intergenic	rs4920799
17903301	Echocardiographic traits	7E-06	Affymetrix [70,897]	1p31.3	PDE4B	rs10493389
17903301	Echocardiographic traits	0.000005	Affymetrix [70,897]	4p15.31	SLIT2	rs666088
17903301	Echocardiographic traits	0.000005	Affymetrix [70,897]	8q13.3	KCNB2	rs10504543
17903301	Echocardiographic traits	0.000006	Affymetrix [70,897]	2q36.1	Intergenic	rs10498091
17903301	Echocardiographic traits	0.000006	Affymetrix [70,897]	1q31.1	FAM5C	rs1935881
17903301	Echocardiographic traits	2E-06	Affymetrix [70,897]	6q15	SPACA1	rs366676
17903301	Endothelial function traits	9.00E-07	Affymetrix [70,897]	10q24.33	OBFC1	rs3814219
17903301	Exercise treadmill test traits	0.000003	Affymetrix [70,897]	4q25	NOLA1	rs6847149
17903301	Exercise treadmill test traits	0.000005	Affymetrix [70,897]	11q22.3	Intergenic	rs746463
17903301	Exercise treadmill test traits	0.000006	Affymetrix [70,897]	8p12	WRN	rs2553268
17903301	Exercise treadmill test traits	4E-06	Affymetrix [70,897]	1q43	RYR2	rs2819770
17903307	Mean forced vital capacity from 2 exams	2E-06	Affymetrix [70,897]	7q21.3	COL1A2	rs441051
17903307	Mean forced vital capacity from 2 exams	4E-06	Affymetrix [70,897]	4q25	Intergenic	rs10516541
17903307	Other pulmonary function traits	1.00E-06	Affymetrix [70,897]	15q11.2	SNRPN	rs3867498
17903307	Other pulmonary function traits	7E-06	Affymetrix [70,897]	14q23.1	Intergenic	rs808225
17903307	Other pulmonary function traits	8E-06	Affymetrix [70,897]	17p12	CDRT4	rs2906966
17903307	Other pulmonary function traits	0.000009	Affymetrix [70,897]	7q34	Intergenic	rs357394
17903307	Other pulmonary function traits	7E-06	Affymetrix [70,897]	1q21.3	IL6R	rs4129267
17903307	Other pulmonary function traits	0.000006	Affymetrix [70,897]	14q22.1	NID2	rs730532
17903307	Other pulmonary function traits	0.000003	Affymetrix [70,897]	21q22.3	ADARB1	rs2838815
17903307	Other pulmonary function traits	0.000005	Affymetrix [70,897]	8q11.22	SNTG1	rs310558
17903307	Other pulmonary function traits	0.000005	Affymetrix [70,897]	2q36.3	RHBDD1	rs3820928
17903307	Other pulmonary function traits	4E-06	Affymetrix [70,897]	15q26.1	FLJ32831	rs1455782
17903294	Factor VII	7E-06	Affymetrix [70,897]	7p22.2	Intergenic	rs10488360
17903294	Factor VII	5.00E-16	Affymetrix [70,897]	13q34	MCF2L, AB116074, AK092739, AK123267, AB0023600, F7, CR603372, F10, PROZ	rs561241
17903294	Factor VII	0.000009	Affymetrix [70,897]	3p26.1	Intergenic	rs4591494
17903294	Factor VII	8E-06	Affymetrix [70,897]	1p36.32	Intergenic	rs966321
17903294	Hemostatic factors and hematological phenotypes	2E-06	Affymetrix [70,897]	1p31.1	NEGR1	rs10493485
17903294	Hemostatic factors and hematological phenotypes	0.000003	Affymetrix [70,897]	5q21.3	Intergenic	rs4460176
17903294	Hemostatic factors and hematological phenotypes	1.00E-06	Affymetrix [70,897]	2p16.2	Intergenic	rs1160297
17903294	Hemostatic factors and hematological phenotypes	2.00E-07	Affymetrix [70,897]	1q23.2	OR10J1,OR10J5	rs4133289
17903294	Hemostatic factors and hematological phenotypes	0.000006	Affymetrix [70,897]	2p16.2	Intergenic	rs2357013
17903294	Hemostatic factors and hematological phenotypes	2.00E-07	Affymetrix [70,897]	14q21.3	MAMDC1	rs7159841
17903294	Hemostatic factors and hematological phenotypes	0.000006	Affymetrix [70,897]	20p12.3	Intergenic	rs6108011
17903294	Hemostatic factors and hematological phenotypes	8E-06	Affymetrix [70,897]	6q25.1	MAP3K7IP2	rs727979
17903294	Hemostatic factors and hematological phenotypes	0.000006	Affymetrix [70,897]	6q25.1	Intergenic	rs636864
17903294	Hemostatic factors and hematological phenotypes	0.000005	Affymetrix [70,897]	4p15.33	Intergenic	rs10489087
17903294	Hemostatic factors and hematological phenotypes	4E-06	Affymetrix [70,897]	1p34.3	FLJ11730, BC016328	rs9253
17903294	Hemostatic factors and hematological phenotypes	0.000005	Affymetrix [70,897]	12q14.2	Intergenic	rs10506458
17903294	Hemostatic factors and hematological phenotypes	4E-06	Affymetrix [70,897]	11q24.1	Intergenic	rs565229
17903294	Hemostatic factors and hematological phenotypes	0.000006	Affymetrix [70,897]	14q32.2	Intergenic	rs10484128
17903294	Hemostatic factors and hematological phenotypes	7.00E-08	Affymetrix [70,897]	11q11	OR5AP2, OR5AR1, OR9G1, OR9G4	rs1397048
17903294	Hemostatic factors and hematological phenotypes	0.000006	Affymetrix [70,897]	10p11.21	ANKRD30A	rs1200821
17903294	Hemostatic factors and hematological phenotypes	0.000006	Affymetrix [70,897]	5q21.1	Intergenic	rs1829883
17903294	Hemostatic factors and hematological phenotypes	2E-06	Affymetrix [70,897]	8q24.13	Intergenic	rs7844723
17848626	Type 2 diabetes and 6 quantitative traits	NS	Affymetrix [66,543]	NR	NR
17846125	Type 2 diabetes	NS	Affymetrix [80,044]	NR	NR
17846124	Type 2 diabetes	NS	Affymetrix [88,142]	NR	NR
17846126	Type 2 diabetes	NS	Affymetrix [82,485]	NR	NR
17827064	Amyotrophic lateral sclerosis	0.000003	Illumina [311,946]	12p11	ITPR2	rs2306677
17804836	Rheumatoid arthritis	4.00E-14	Illumina [297,086]	9q34	TRAF1-C5	rs3761847
17804836	Rheumatoid arthritis	2.00E-11	Illumina [297,086]	1p13.2	PTPN22	rs2476601
17804836	Rheumatoid arthritis	1.00E-108	Illumina [297,086]	6p21.32	HLA-DRB1	rs660895
17804789	Crohn's disease	1.00E-08	Perlegen [164,279]	1p31.3	IL23R	rs11209003,rs11209002,rs2064689,rs1004819,rs2902440,rs11465802,rs2201841,rs11465804,rs11209026,rs1343151,rs10889676,rs10889677,rs9988642,rs12567232,rs6669582,rs10789230
17804789	Crohn's disease	6.00E-17	Perlegen [164,279]	16q12.1	NOD2	rs5743289
17804789	Crohn's disease	2.00E-07	Perlegen [164,279]	1p31.3	IL23R	rs11209002,rs2064689,rs1004819,rs2902440,rs11465802,rs2201841,rs11465804,rs11209026,rs1343151,rs10889676,rs10889677,rs9988642,rs12567232,rs6669582,rs10789230,rs11209003
17767159	F-cell distribution	6.00E-31	Illumina [308,015]	2p15.1	BCL11A	rs1427407
17767159	F-cell distribution	3.00E-36	Illumina [308,015]	6q23.3	Intergenic	rs9399137
17767159	F-cell distribution	2.00E-38	Illumina [308,015]	11p15.5	HBB	NR
17767157	Height	6.00E-16	Affymetrix [364,301]	12q14.3	HMGA2	rs1042725
17690259	Exfoliation glaucoma	3.00E-21	Illumina [304,250]	15q24.1	LOXL1	rs3825942
17684544	Inflammatory bowel syndrome	1.00E-21	Affymetrix [92,387]	16q12.1	CARD15	rs2076756
17684544	Inflammatory bowel syndrome	0.000003	Affymetrix [92,387]	11p15.1	NELL1	rs1793004
17684544	Inflammatory bowel syndrome	4.00E-07	Affymetrix [92,387]	5p13.1	PTGER4	rs1992660
17671248	Amyotrophic lateral sclerosis	NS	Affymetrix and Illumina [776,955]	NR	NR
17653210	Diabetic nephropathy	8E-06	NR [~80,000]	7p14.2	ELMO1	rs741301
17667963	Neuroticism	2E-06	Affymetrix [452,574] (pooled)	5q11.2	PDE4D	rs702543
17660530	Multiple sclerosis	3.00E-08	Affymetrix [334,923]	10p15.1	IL2RA	rs12722489
17660530	Multiple sclerosis	3.00E-07	Affymetrix [334,923]	5p13.2	IL7RA	rs6897932
17660530	Multiple sclerosis	9.00E-81	Affymetrix [334,923]	6p21.32	HLA-DRA	rs3135388
17660530	Multiple sclerosis	4E-06	Affymetrix [334,923]	16p13	KIAA0350	rs6498169
17660530	Multiple sclerosis	8E-06	Affymetrix [334,923]	1p22	RPL5	rs6604026
17660530	Multiple sclerosis	8E-06	Affymetrix [334,923]	9q33	DBC1	rs10984447
17611496	Asthma	9.00E-11	Illumina [307,328]	17q21	Intergenic	rs7216389
17658951	Obesity-related traits	9.00E-07	Affymetrix [362,129]	16q12.2	FTO	rs9930506
17658951	Obesity-related traits	3.00E-08	Affymetrix [362,129]	16q12.2	FTO	rs9930506
17658951	Obesity-related traits	9.00E-07	Affymetrix [362,129]	16q12.2	FTO	rs9930506
17641165	HIV1 viral setpoint	NS	Illumina [535,101]	NR	NR
17634447	Restless legs syndrome	1.00E-17	Illumina [306,937]	6p21.2	BTBD9	rs3923809
17634449	Coronary disease	3.00E-08	Affymetrix [377,857]	6q25.1	MTHFD1L	rs6922269
17634449	Coronary disease	2.00E-07	Affymetrix [377,857]	2q36.3	pseudogene	rs2943634
17634449	Coronary disease	1.00E-06	Affymetrix [377,857]	1q41	MIA3	rs17465637
17634449	Coronary disease	2.00E-07	Affymetrix [377,857]	15q22.33	SMAD3	rs17228212
17634449	Coronary disease	9.00E-08	Affymetrix [377,857]	10q11.21	CXCL12	rs501120
17634449	Coronary disease	4.00E-09	Affymetrix [377,857]	1p13.3	PSRC1	rs599839
17634449	Coronary disease	3.00E-19	Affymetrix [377,857]	9p21.3	Intergenic	rs1333049
17637780	Restless legs syndrome	3.00E-28	Affymetrix [236,758]	2p14	MEIS1	rs2300478
17637780	Restless legs syndrome	4.00E-18	Affymetrix [236,758]	6p21.2	BTBD9	rs9296249
17637780	Restless legs syndrome	1.00E-15	Affymetrix [236,758]	15q23	MAP2K5, LBXCOR1	rs12593813
17632509	Gallstones	1.00E-14	Affymetrix [382,492]	2p21	ABCG8	rs11887534
17632545	Type 1 diabetes	7.00E-11	Illumina [543,071]	16p13.13	KIAA0350	rs2903692
17632545	Type 1 diabetes	1.00E-07	Illumina [543,071]	1p13.2	PTPN22	rs2476601
17632545	Type 1 diabetes	4.00E-09	Illumina [543,071]	11p15.5	INS	rs1004446
17632545	Type 1 diabetes	1.00E-16	Illumina [543,071]	6p21.32	HLA-E	rs2647044
17618284	Colorectal cancer	1.00E-14	Illumina [547,647]	8q24.21	Intergenic	rs6983267
17618283	Colorectal cancer	3.00E-11	Illumina and Affymetrix [99,632]	8q24.21	ORF DQ515897	rs10505477
17603472	Atrial fibrillation/atrial flutter	3.00E-41	Illumina [316,515]	4q25	PITX2,ENPEP	rs2200733
17603472	Atrial fibrillation/atrial flutter	7.00E-11	Illumina [316,515]	4q25	PITX2,ENPEP	rs10033464
17603485	Prostate cancer	1.00E-11	Illumina [310,520]	17q12	TCF2	rs4430796
17603485	Prostate cancer	3.00E-10	Illumina [310,520]	17q24.3	Intergenic	rs1859962
17668382	Type 2 diabetes	5.00E-08	Illumina [315,917]	10q25.2	TCF7L2	rs7903146
17668382	Type 2 diabetes	0.000006	Illumina [315,917]	2q12.1	Intergenic	rs6712932
17558408	Celiac disease	1.00E-14	Illumina [310,605]	4q27	KIAA1109,TENR,IL2,IL21	rs6822844
17558408	Celiac disease	1.00E-19	Illumina [310,605]	6p21.32	HLA-DQA1	rs2187668
17553421	APOE*e4 carriers with late onset Alzheimer's disease	1.00E-10	Affymetrix [312,316]	11q14.1	GAB2	rs2373115
17554300	Bipolar disorder	6.00E-08	Affymetrix [469,557]	16p12.1	PALB2,NDUFAB1,DCTN5	rs420259
17554300	Bipolar disorder	4E-06	Affymetrix [469,557]	6p21	NR	rs6458307
17554300	Bipolar disorder	0.000005	Affymetrix [469,557]	3q27	NR	rs683395
17554300	Bipolar disorder	8E-06	Affymetrix [469,557]	14q32.33	NR	rs11622475
17554300	Bipolar disorder	7E-06	Affymetrix [469,557]	14q23.1	NR	rs10134944
17554300	Bipolar disorder	7E-06	Affymetrix [469,557]	2q37	NR	rs2953145
17554300	Bipolar disorder	7E-06	Affymetrix [469,557]	20p13	NR	rs3761218
17554300	Coronary disease	1.00E-13	Affymetrix [469,557]	9p21.3	CDKN2A,CDKN2B	rs1333049
17554300	Coronary disease	2E-06	Affymetrix [469,557]	1q43	NR	rs17672135
17554300	Coronary disease	4E-06	Affymetrix [469,557]	22q12	NR	rs688034
17554300	Coronary disease	0.000006	Affymetrix [469,557]	16q23	NR	rs8055236
17554300	Crohn's disease	4.00E-08	Affymetrix [469,557]	3p21.31	BSN, MST1	rs9858542
17554300	Crohn's disease	3.00E-07	Affymetrix [469,557]	5q33.1	IRGM	rs1000113
17554300	Crohn's disease	0.000003	Affymetrix [469,557]	5q31.1	Intergenic	rs6596075
17554300	Crohn's disease	2E-06	Affymetrix [469,557]	10q21.2	Intergenic	rs10761659
17554300	Crohn's disease	2.00E-12	Affymetrix [469,557]	5p13.1	Intergenic	rs17234657
17554300	Crohn's disease	5.00E-14	Affymetrix [469,557]	2q37.1	ATG16L1	rs10210302
17554300	Crohn's disease	6.00E-12	Affymetrix [469,557]	1p31.3	IL23R	rs11805303
17554300	Crohn's disease	4.00E-11	Affymetrix [469,557]	16q12.1	NOD2	rs17221417
17554300	Crohn's disease	0.000009	Affymetrix [469,557]	10p15.1	NR	rs6601764
17554300	Crohn's disease	4E-06	Affymetrix [469,557]	7q36.1	NR	rs7807268
17554300	Crohn's disease	6.00E-08	Affymetrix [469,557]	10q24.2	NKX2-3	rs10883365
17554300	Crohn's disease	2.00E-07	Affymetrix [469,557]	18p11.21	PTPN2	rs2542151
17554300	Crohn's disease	2E-06	Affymetrix [469,557]	6p21	NR	rs9469220
17554300	Hypertension	8.00E-07	Affymetrix [469,557]	1q43	RYR2,CHRM3,ZP4	rs2820037
17554300	Hypertension	0.000006	Affymetrix [469,557]	15q26	NR	rs2398162
17554300	Rheumatoid arthritis	4.00E-07	Affymetrix [469,557]	7q32.3	Intergenic	rs11761231
17554300	Rheumatoid arthritis	1.00E-06	Affymetrix [469,557]	22q13	NR	rs743777
17554300	Rheumatoid arthritis	2E-06	Affymetrix [469,557]	21q22	NR	rs2837960
17554300	Rheumatoid arthritis	5.00E-75	Affymetrix [469,557]	6p21.32	MHC	rs6457617
17554300	Rheumatoid arthritis	6.00E-25	Affymetrix [469,557]	1p13.2	PTPN22	rs6679677
17554300	Rheumatoid arthritis	8.00E-27	Affymetrix [469,557]	6p21.32	HLA-DRB1	rs615672
17554300	Rheumatoid arthritis	0.000009	Affymetrix [469,557]	4p15.2	NR	rs3816587
17554300	Type 1 diabetes	1.00E-11	Affymetrix [469,557]	12q13.2	ERBB3	rs11171739
17554300	Type 1 diabetes	2E-06	Affymetrix [469,557]	4q27	NR	rs6534347
17554300	Type 1 diabetes	0.000005	Affymetrix [469,557]	5q31.1	NR	rs17166496
17554300	Type 1 diabetes	0	Affymetrix [469,557]	6p21.32	MHC	rs9272346
17554300	Type 1 diabetes	5.00E-26	Affymetrix [469,557]	1p13.2	PTPN22	rs6679677
17554300	Type 1 diabetes	5.00E-08	Affymetrix [469,557]	12p13.31	NR	rs3764021
17554300	Type 1 diabetes	2.00E-14	Affymetrix [469,557]	12q24.13	SH2B3,LNK,TRAFD1,PTPN1	rs17696736
17554300	Type 1 diabetes	5.00E-07	Affymetrix [469,557]	16p13.13	KIAA0350	rs12708716
17554300	Type 1 diabetes	7.00E-07	Affymetrix [469,557]	12p13	NR	rs11052552
17554300	Type 1 diabetes	0.000003	Affymetrix [469,557]	4q27	NR	rs17388568
17554300	Type 2 diabetes	3.00E-07	Affymetrix [469,557]	6p22.3	CDKAL1	rs9465871
17554300	Type 2 diabetes	2.00E-07	Affymetrix [469,557]	16q12.2	FTO	rs9939609
17554300	Type 2 diabetes	5.00E-12	Affymetrix [469,557]	10q25.2	TCF7L2	rs4506565
17554300	Type 2 diabetes	0.000009	Affymetrix [469,557]	4q27	NR	rs7659604
17554300	Type 2 diabetes	0.000003	Affymetrix [469,557]	3p14	NR	rs358806
17554300	Type 2 diabetes	7E-06	Affymetrix [469,557]	12q15	NR	rs1495377
17554300	Type 2 diabetes	7E-06	Affymetrix [469,557]	12q13	NR	rs12304921
17554261	Crohn's disease	3.00E-08	see WTCCC	1q31.2	Intergenic	rs10801047
17554261	Crohn's disease	5.00E-08	see WTCCC	3p21.31	MST1	rs9858542
17554261	Crohn's disease	2.00E-10	see WTCCC	5q33.1	IRGM	rs13361189
17554261	Crohn's disease	4.00E-10	see WTCCC	10q24.2	NKX2-3	rs10883365
17554261	Crohn's disease	3.00E-08	see WTCCC	18p11.21	PTPN2	rs2542151
17554261	Crohn's disease	3.00E-18	see WTCCC	5p13.1	Intergenic	rs9292777
17554261	Crohn's disease	0.000009	see WTCCC	5q33.3	IL12B	rs6887695
17554261	Crohn's disease	2.00E-07	see WTCCC	1q24.3	Intergenic	rs12035082
17554261	Crohn's disease	5.00E-07	see WTCCC	21q22.2	Intergenic	rs2836754
17554260	Type 1 diabetes	2.00E-16	see WTCCC	12q24.13	C12orf30	rs17696736
17554260	Type 1 diabetes	2.00E-20	see WTCCC	12q13.2	ERBB3	rs2292239
17554260	Type 1 diabetes	3.00E-18	see WTCCC	16p13.13	KIAA0350	rs12708716
17554260	Type 1 diabetes	1.00E-14	see WTCCC	18p11.21	PTPN2	rs2542151
17554260	Type 1 diabetes	2.00E-11	see WTCCC	2q24.2	IFIH1	rs1990760
17554260	Type 1 diabetes	8E-06	see WTCCC	5p13.2	IL7R	rs6897932
17554260	Type 1 diabetes	8E-06	see WTCCC	5p13.2	CAPSL	rs1445898
17554260	Type 1 diabetes	2.00E-80	see WTCCC	1p13.2	PTPN22	rs2476601
17554260	Type 1 diabetes	2.00E-07	see WTCCC	11p15.5	INS	rs3741208
17554260	Type 1 diabetes	8.00E-24	see WTCCC	1p13.2	PHTF1, PTPN22	rs6679677
17554260	Type 1 diabetes	0.000005	see WTCCC	2p11.2	AFF3, LOC150577	rs9653442
17554260	Type 1 diabetes	1.00E-08	see WTCCC	18q22.2	CD226	rs763361
17529967	Breast cancer	2.00E-76	Perlegen [205,586]	10q26.13	FGFR2	rs2981582
17529967	Breast cancer	0.000009	Perlegen [205,586]	5p12	Intergenic	rs981782
17529967	Breast cancer	1.00E-36	Perlegen [205,586]	16q12.1	TNCR9,LOC643714	rs3803662
17529967	Breast cancer	7.00E-20	Perlegen [205,586]	5q11.2	MAP3K1	rs889312
17529967	Breast cancer	3.00E-09	Perlegen [205,586]	11p15.5	LSP1	rs3817198
17529967	Breast cancer	5.00E-12	Perlegen [205,586]	8q24.21	Intergenic	rs13281615
17529973	Breast cancer	1.00E-10	Illumina [528,173]	10q26.13	FGFR2	rs1219648
17529974	Breast cancer	1.00E-13	Illumina [311,524]	2q35	Intergenic	rs13387042
17529974	Breast cancer	6.00E-19	Illumina [311,524]	16q12.1	TNRC9	rs3803662
17505501	Response to ximelagatran treatment	0.000009	Perlegen [~266,722]	6p21.3	HLA-DRB1
17486107	Bipolar disorder	2.00E-08	Illumina [555,235] (pooled)	13q14.11	DGKH	rs1012053
17434096	Stroke	0.000006	Illumina [408,803]	13q21.1	Intergenic	rs9536591
17434096	Stroke	7.00E-07	Illumina [408,803]	18p11.2	IMPA2	rs7506045
17434096	Stroke	0.000006	Illumina [408,803]	7p21	Intergenic	rs10486776
17434096	Stroke	0.000009	Illumina [408,803]	6q21	AIM1	rs783396
17478679	Myocardial infarction	1.00E-20	Illumina [305,953]	9p21.3	CDKN2A,CDKN2B	rs10757278
17478681	Coronary disease	NS	Perlegen [72,864]	NR	NR
17470457	Episodic memory	NS	Affymetrix [~502,627] (pooled)	NR	NR
17463246	Triglycerides	3.00E-13	Affymetrix [386,731]	19q13.32	APOE cluster	rs4420638
17463246	Triglycerides	0.000003	Affymetrix [386,731]	16q13	CETP	rs1800775
17463246	Triglycerides	7.00E-07	Affymetrix [386,731]	2p24.1	APOB	rs693
17463246	Triglycerides	3.00E-13	Affymetrix [386,731]	16q13	CETP	rs1800775
17463246	Triglycerides	5.00E-07	Affymetrix [386,731]	8p21.3	LPL	rs328
17463246	Type 2 diabetes	6.00E-10	Affymetrix [386,731]	10q23.33	HHEX	rs1111875
17463246	Type 2 diabetes	8.00E-15	Affymetrix [386,731]	9p21.3	CDKN2A,CDKN2B	rs10811661
17463246	Type 2 diabetes	4.00E-11	Affymetrix [386,731]	6p22.3	CDKAL1	rs7754840
17463246	Type 2 diabetes	9.00E-16	Affymetrix [386,731]	3q27.2	IGF2BP2	rs4402960
17463246	Type 2 diabetes	2E-06	Affymetrix [386,731]	3p25.2	PPARG	rs1801282
17463246	Type 2 diabetes	5.00E-08	Affymetrix [386,731]	8q24.11	SLC30A8	rs13266634
17463246	Type 2 diabetes	1.00E-48	Affymetrix [386,731]	10q25.2	TCF7L2	rs7903146
17463246	Type 2 diabetes	7.00E-11	Affymetrix [386,731]	11p15.1	KCNJ11	rs5219
17463248	Type 2 diabetes	2E-06	Illumina [315,635]	3p25.2	PPARG	rs1801282
17463248	Type 2 diabetes	6.00E-10	Illumina [315,635]	10q23.33	HHEX	rs1111875
17463248	Type 2 diabetes	4.00E-07	Illumina [315,635]	11p12	Intergenic	rs9300039
17463248	Type 2 diabetes	8.00E-15	Illumina [315,635]	9p21.3	CDKN2A, CDKN2B	rs10811661
17463248	Type 2 diabetes	4.00E-11	Illumina [315,635]	6p22.3	CDKAL1	rs7754840
17463248	Type 2 diabetes	9.00E-16	Illumina [315,635]	3q27.2	IGF2BP2	rs4402960
17463248	Type 2 diabetes	7.00E-11	Illumina [315,635]	11p15.1	KCNJ11	rs5219
17463248	Type 2 diabetes	1.00E-48	Illumina [315,635]	10q25.2	TCF7L2	rs7903146
17463248	Type 2 diabetes	5.00E-08	Illumina [315,635]	8q24.11	SLC30A8	rs13266634
17460697	Type 2 diabetes	2.00E-10	Illumina [313,179 SNPs; 339,846 2-SNP haplotypes]	10q25.2	TCF7L2	rs7903146
17460697	Type 2 diabetes	0.000003	Illumina [313,179 SNPs; 339,846 2-SNP haplotypes]	8q24.11	SLC30A8	rs13266634
17460697	Type 2 diabetes	8.00E-09	Illumina [313,179 SNPs; 339,846 2-SNP haplotypes]	6p22.3	CDKAL1	rs7756992
17463249	Type 2 diabetes	1.00E-12	Affymetrix [393,453]	16q12.2	FTO	rs8050136
17463249	Type 2 diabetes	6.00E-10	Affymetrix [393,453]	10q23.33	HHEX	rs5015480
17463249	Type 2 diabetes	9.00E-16	Affymetrix [393,453]	3q27.2	IGF2BP2	rs4402960
17463249	Type 2 diabetes	8.00E-15	Affymetrix [393,453]	9p21.3	CDKN2A/B	rs10811661
17463249	Type 2 diabetes	4.00E-11	Affymetrix [393,453]	6p22.3	CDKAL1	rs10946398
17463249	Type 2 diabetes	1.00E-07	Affymetrix [393,453]	9p21.3	CDKN2B	rs564398
17463249	Type 2 diabetes	2E-06	Affymetrix [393,453]	3p25.2	PPARG	rs1801282
17463249	Type 2 diabetes	5.00E-11	Affymetrix [393,453]	11p15.1	KCNJ11	rs5215
17463249	Type 2 diabetes	1.00E-48	Affymetrix [393,453]	10q25.2	TCF7L2	rs7901695
17463249	Type 2 diabetes	5.00E-08	Affymetrix [393,453]	8q24.11	SLC30A8	rs13266634
17435756	Crohn's disease	1.00E-13	Illumina [304,413]	2q37.1	ATG16L1	rs2241880
17435756	Crohn's disease	7.00E-14	Illumina [304,413]	16q12.1	CARD15	rs2076756
17435756	Crohn's disease	3.00E-12	Illumina [304,413]	1p31.3	IL23R	rs7517847
17435756	Crohn's disease	1.00E-10	Illumina [304,413]	10q21.2	Intergenic	rs224136
17434869	Body mass index	2.00E-20	Affymetrix [490,032]	16q12.2	FTO	rs9939609
17407593	Nicotine dependence	NS	Affymetrix [~520,000] (pooled)	NR	NR
17474819	Late onset Alzheimer's disease	1.00E-39	Affymetrix [~502,627]	19q13.32	APOE	rs4420638
17401366	Prostate cancer	3.00E-15	Illumina [316,515]	8q24.21	Intergenic	rs10033464
17401366	Prostate cancer	6.00E-18	Illumina [316,515]	8q24.21	Intergenic	rs1447295
17401366	Prostate cancer	1.00E-12	Illumina [316,515]	8q24.21	Intergenic	rs16901979
17395743	End-stage renal disease	2E-06	Affymetrix [115,352]	8q24.21	PVT1	rs2648875
17401363	Prostate cancer	2.00E-14	Illumina [538,548]	8q24.21	Intergenic	rs1447295
17401363	Prostate cancer	9.00E-13	Illumina [538,548]	8q24.21	Intergenic	rs6983267
17522711	Schizophrenia	4.00E-07	Affymetrix [439,511]	Xp22.33,Yp11.32	CSF2RA,IL3RA	rs4129148
17357082	Progressive supranuclear palsy	NS	Affymetrix [428,867]	NR	NR
17447842	Crohn's disease	2.00E-18	Illumina [302,451]	1p31.3	IL23R	rs11209026
17447842	Crohn's disease	1.00E-06	Illumina [302,451]	16q12.1	CARD15	rs5743289
17447842	Crohn's disease	2.00E-12	Illumina [302,451]	5p13.1	Intergenic	rs1373692
17362836	Amyotrophic lateral sclerosis	7.00E-07	Illumina [549,062]	10q26.13	Intergenic	rs4363506
17362836	Amyotrophic lateral sclerosis	2E-06	Illumina [549,062]	2p24	Intergenic	rs16984239
17362836	Amyotrophic lateral sclerosis	0.000003	Illumina [549,062]	8q24.2	Intergenic	rs12680546
17362836	Amyotrophic lateral sclerosis	0.000005	Illumina [549,062]	20q13.2	ZFP64	rs6013382
17362836	Amyotrophic lateral sclerosis	0.000006	Illumina [549,062]	9q31.3	SUSD1	rs2782931
17362836	Amyotrophic lateral sclerosis	0.000009	Illumina [549,062]	4q31.3	KlAA1727	rs11099864
17293876	Type 2 diabetes	0.000003	Illumina [392,935]	10q23.33	HHEX	rs1111875
17293876	Type 2 diabetes	2.00E-34	Illumina [392,935]	10q25.3	TCF7L2	rs7903146
17293876	Type 2 diabetes	6.00E-08	Illumina [392,935]	8q24.11	SLC30A8	rs13266634
17223258	Lung cancer	NS	Affymetrix [~116,204] (pooled)	NR	NR
17158188	Nicotine dependence	2E-06	Perlegen [2.4 million] (pooled)	21q22.2	NR	rs2836823
17158188	Nicotine dependence	0.000006	Perlegen [2.4 million] (pooled)	10q21.3	CTNNA3	rs4142041
17099884	Addiction	NS	Affymetrix [639,401]	NR	NR
17068223	Inflammatory bowel disease	4.00E-11	Illumina [308,332]	1p31.3	IL23R	rs11209026
17068223	Inflammatory bowel disease	5.00E-10	Illumina [308,332]	16q12.1	CARD15	rs2076756
17068223	Inflammatory bowel disease	4.00E-13	Illumina [308,332]	1p31.3	IL23R	rs7517847
17053149	Memory performance	NS	Affymetrix [178,390]	NR	NR
17053108	Wet age-related macular degeneration	8.00E-12	Affymetrix [97,824]	10q26	HTRA1	rs11200638
17052657	Parkinson's disease	7E-06	Illumina [408,803]	11q14	DLG2	rs10501570
17052657	Parkinson's disease	2E-06	Illumina [408,803]	4q13.2	BRDG1	rs2242330
17052657	Parkinson's disease	2E-06	Illumina [408,803]	10q11.21	Intergenic	rs1480597
16648850	QT interval prolongation	1.00E-10	Affymetrix [88,500]	1q23.3	NOS1AP	rs10494366
16614226	Obesity	NS	Affymetrix [86,604]	NR	NR
16252231	Parkinson's disease	8E-06	Perlegen [198,345]	5p15.2	SEMA5A	rs7702187
15761122	Age-related macular degeneration	4.00E-08	Affymetrix [103,611]	1q31	CFH	rs380390